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Abstract
An estimated 50% of individuals with long-term HIV infection are affected by the onset of progressive 
neurological and cognitive complications referred to as HIV-associated neurocognitive disorders (HAND). 
While the molecular mechanisms underlying pathology in HAND remain poorly understood, 
synaptodendritic damage has emerged as a hallmark of HIV infection of the CNS. This damage is likely 
mediated by a combination of indirect mechanisms involving the release of inflammatory mediators and 
viral proteins from infected glial cells, and direct effects mediated by the interaction of neurotoxic viral 
proteins with neuronal receptors. The neurotoxic HIV envelope glycoprotein gp120 interacts with 
neuronal receptors CCR5 and CXCR4 to induce the coalescence of lipid raft domains into large, stable 
platforms— a proposed mechanism for clustering components of receptor-activated signaling cascades. 
The interaction of proteins with lipid-raft localized receptors as a mechanism of regulating pathologic 
signaling has been observed in other neurodegenerative diseases, most notably in Alzheimer's disease, 
where amyloid-β (Aβ) oligomers interact with lipid raft-anchored cellular prion protein PrPC to activate a 
pathway leading to the formation of cofilin-actin rods-like inclusions (rods) in neuronal processes. Rods 
have been linked to synaptic dysfunction via sequestration of cofilin and the disruption of vesicular 
transport resulting from the occlusion of neurites in which they form. Given similarities in neuronal 
response to gp120 and Aβ, we sought to assess the ability of gp120 to induce rods. Here, we report viral 
envelope protein gp120 induces the formation of cofilin-actin rods in E16 mouse hippocampal neurons 
via a signaling pathway common to oligomeric, soluble amyloid-β and inflammatory cytokines. Our 
studies demonstrate gp120 binding to either chemokine co-receptor CCR5 or CXCR4 is capable of 
inducing rod formation and signaling through this pathway requires the NADPH oxidase-mediated 
formation of superoxide (O2-) and the expression of cellular prion protein (PrPC). These results link 
gp120-mediated oxidative stress formation to the generation rods in a previously undescribed mechanism 
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Chapter 1: General Introduction
Human immunodeficiency virus (HIV), a member of the lentivirus genus of the Retroviridae 
family of RNA viruses, is the etiologic agent responsible for acquired immune deficiency syndrome 
(AIDS) and its associated complications, which has been responsible for 35 million deaths and more than 
70 million infections worldwide since first emerging in the early 1980s (1). As with other lentiviruses, 
HIV causes chronic disease in infected individuals with a characteristic period of clinical latency and 
persistent viral replication. Advances in understanding the virus and improvements in diagnosis, treatment, 
and outcomes of disease have led to a substantial reduction in HIV-related mortality. However, as the 
epidemiology of HIV/AIDS shifts from an acute infection to chronic disease, new challenges emerge in 
terms of management of long-term infection and associated comorbidities that can have profound impacts 
on quality of life for infected individuals. HIV isolates are grouped into two types of which HIV-type 1 
(HIV-1) is the strain responsible for the present worldwide epidemic of AIDS and is the subject of the 
following studies.
1.1. HIV-associated neurodegenerative disorder
While the primary pathophysiology of HIV is typically associated with immune dysfunction and 
dysregulation, cognitive impairments have been a long-recognized consequence of infection. The 
spectrum of progressive neurological complications of infection are characterized into three groups, 
ranging from asymptomatic neurocognitive impairments (ANI) to mild neurocognitive disorders (MND) 
and the more severe HIV-associated dementia (HAD) (2). These cognitive dysfunctions, referred to under 
the umbrella term HIV-associated neurological disorders (HAND) are diagnosed via neuropsychological 
testing and functional status assessments, and have been reported to affect 20-50% of HIV-infected 
individuals (2, 3). Since the implementation of combined antiretroviral therapy (cART) as the primary 
treatment regimen for HIV/AIDS in the mid 1990's there has been a significant reduction in the incidence 
of the severest form of HAND, now rarely seen in developed countries in the post-cART era. However, 
prevalence of milder forms of HAND remain stable and are expected to rise with the aging population of 
HIV-infected individuals (4). In the United States, of the 1.2 million people living with HIV an estimated 
50% are older than 50 years of age, with an expected increase to 70% of the population of infected 
individuals by the year 2030 (5).
Sections 1-4 published as Smith L.K., Kuhn, T.B., Chen, J., and Bamburg J.R. (2018) HIV Associated 
Neurodegenerative Disorders: A New Perspective on the Role of Lipid Rafts in Gp120-Mediated Neurodegeneration.
Current HIV Research doi: 10.2174/1570162X16666181003144740.
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Complications from HIV infection may overlap with other age-associated neurodegenerative diseases 
such as Alzheimer's disease. Several groups have reported an increased accumulation of amyloid-β 
precursor protein (APP) in the brains of HIV infected patients (6-8). It is hypothesized that 
neuroinflammation resulting from the activity of proinflammatory HIV proteins, including Tat and gp120, 
as well as prolonged cART and aging all contribute to the overall increase in amyloid deposition. Thus, 
long term infection with HIV might contribute to the worsening of age-related neuronal damage with 
evidence increasingly suggestive that HIV infection exacerbates age-associated cognitive decline (9, 10). 
With the shift of HIV infection to a chronic disease in the post-cART era, so too does the potential for 
significant effects on cognitive decline in the aging population of infected individuals.
HIV invades the central nervous system (CNS) during early infection and viral RNA has been 
detected in samples of cerebral spinal fluid (CSF) and in the brain within weeks of initial viral exposure 
with compartmentalized HIV replication detected in the CNS within four months of infection (11). The 
early infiltration of independently replicating virus within the CNS may represent a mechanism by which 
the virus establishes a pharmacological and immunological sanctuary site, owing to the inability of most 
antiretroviral drugs to cross the blood brain barrier and the restricted entry of lymphocyte populations into 
the brain (12-16). Assessment of cognitive impairment in a population of long-standing aviremic patients 
yielded an estimated prevalence of HAND in individuals adherent to cART regimens at 69% (17). Indeed, 
numerous studies support the occurrence of cognitive impairment in HIV-infected individuals despite 
cART-mediated suppression of HIV viral load in plasma (18-20). HIV RNA viral load in the CSF has 
been reported to be significantly correlated with neurological dysfunction independent of plasma viral 
load (21). Thus, evidence increasingly supports the CNS as a site of persistent low-level HIV infection.
HIV infects the CNS via a “Trojan Horse” model of blood-brain barrier (BBB) crossing that is 
characteristic of lentiviral spread in the bloodstream and CSF (22). HIV infiltrates the brain via infected 
CD4+ macrophages and lymphocytes, allowing for transmigration of virus to perivascular spaces of the 
CNS while evading immune detection. Here, the infection is propagated in populations of perivascular 
macrophages and microglia (23). Infected cells secrete neurotoxic viral proteins, inflammatory cytokines, 
and small metabolites that may contribute to further disruption of the BBB and promote continued influx 
of the virus (24, 25).
HIV infection of the CNS is associated with activation of microglia and astrocytes, as well as the 
induction of inflammatory and neurotoxic insults which contribute to the neurodegeneration and cognitive 
decline characteristic of HAND. Despite the prevalence of HIV-associated cognitive dysfunctions, the 
molecular and cellular mechanisms underlying HAND are poorly understood and are thought to consist of 
a combination of direct viral infection of cells of the CNS and indirect mechanisms involving host factors 
and neurotoxic effects of HIV-associated proteins.
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Notably, HIV viral proteins Tat and gp120 have been implicated in affecting BBB integrity and 
promoting viral entry into the CNS. Tat (HIV transactivator of transcription), a viral regulatory protein 
responsible for activating viral transcription, is one of the first HIV proteins to be expressed following 
infection (26). Tat has been recognized for its neurotoxic role in HAND and similarly to gp120 is found 
in extracellular spaces in soluble form (27). In the CNS, Tat has demonstrated neurotoxicity, including 
induction of neuronal oxidative stress via secretion of cytokines and chemokines and neuronal apoptosis 
via a pathway of NMDA receptor-mediated glutamate excitotoxicity (28, 29). Tat has been detected in 
postmortem brains and CSF of HIV infected subjects, and numerous studies support Tat-mediated 
permeabilization of the BBB (30-32). A recent study utilizing a Tat-expressing transgenic murine model 
to examine the influence of Tat expression on BBB integrity found Tat exposure is sufficient to 
destabilize BBB integrity and increase the presence of activated perivascular macrophages and microglia 
in an in vivo model of HAND (33). These results support previous evidence that Tat-dependent disruption 
to the BBB may also contribute to glial activation and inflammation that underlie indirect neuronal injury 
observed in HAND (34). While a role for Tat in HAND is clearly supported, Tat's contribution is beyond 
the scope of this dissertation and is discussed elsewhere in greater detail (35).
Viral surface protein gp120 has also been linked to functional impairment of the BBB. As well as 
documented gp120 activation of proinflammatory genes and increased migration of monocytes across the 
BBB, a significant increase in permeability of brain endothelial cells in the presence of circulating gp120 
has been reported (36, 37). In both reports, removal of gp120 restored integrity of the BBB. The 
remainder of this introduction will focus on gp120-mediated neurotoxicity.
1.2 HIV Gp-120
The entry of HIV to host cells is mediated by envelope glycoproteins gp120 and gp41. The non- 
covalently linked gp120 and gp41 interact to form a trimer of gp120/gp41 heterodimers where gp120 
serves as a viral surface protein recognizing host CD4 and chemokine co-receptors and the 
transmembrane gp41 functions as a fusion peptide to assist in viral-host membrane fusion (38). Given the 
relatively weak association between the two subunits, gp120 shed from the trimer is well documented (39, 
40). Indeed, high levels of monomeric soluble gp120 have been detected in secondary lymphoid organs of 
chronically infected individuals, while high levels of anti-gp120 antibodies have been detected in cerebral 
spinal fluid (CSF) of patients with HAD (41-43).
1.2.1 Gp120 interaction with membrane lipid raft domains
Binding of viral surface glycoprotein gp120 to receptors is restricted to host-cell lipid raft 
domains (Figure 1.1) (44). Lipid rafts are small (10-200nm), dynamic cholesterol and sphingolipid 
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enriched microdomains in the plasma membrane that serve to compartmentalize cellular processes, 
facilitating protein-lipid and protein-protein interactions and signal transduction events (45-47). 
Membrane rafts have been implicated as critical signaling nodes of several neurological pathologies 
including Alzheimer's and Parkinson's diseases where they appear to play a role in mediating pathologic 
signal transduction characteristic of these neurodegenerative diseases (48, 49). It has been demonstrated 
that many pathogens in addition to HIV exploit the lipid raft environment, including influenza and Ebola, 
at various stages of the viral lifecycle (viral entry, assembly, and budding) (50). The life cycle of HIV is 
intricately tied to raft domains and requires interaction with raft-localized receptors for initial binding, 
viral-host membrane fusion, virion assembly, and subsequent release of viral progeny (51-54).
Several studies support the crucial role of rafts for HIV target receptor function. Fluorescence 
resonance energy transfer imaging has revealed a requirement for lipid rafts in the interaction between 
CD4 and co-receptors, thus suggesting receptor localization to lipid raft domains (55). CD4 is enriched in 
lipid raft domains where it serves to facilitate coalescence of these domains and mediates the attachment 
and entry of HIV into host cells (53, 55, 56). Site-directed mutagenesis has been used to identify a short 
sequence of positively charged amino acid residues in the cytoplasmic domain of CD4 controlling its 
targeted partitioning into raft domains (57). In addition to CD4, HIV co-receptors CCR5 and CXCR4 are 
also found in detergent resistant membrane fractions following exposure to HIV gp120. Host membrane 
cholesterol is but one particular lipid that is required for HIV infection, as evidenced by the blocking of 
viral entry following treatment with the cholesterol chelator methyl-β-cyclodextrin. Interestingly, the 
specific lipid environment of raft domains appears to be necessary for the conformational stability and 
function of these receptors and putative cholesterol binding sites in both chemokine receptors that appear 
to support their localization to raft domains have been identified (58). These results support previous 
studies identifying a requirement for cholesterol in conformational integrity and function of both CCR5 
and CXCR4 receptors (52, 59).
1.2.2 Gp120 co-receptor tropism
In most cases, gp120 binding to CD4 alone is not enough to induce membrane fusion, and 
interaction with a secondary co-receptor is required (60). Gp120/CD4 interaction initiates a series of 
successive conformational changes in gp120 structure, ultimately exposing the third variable region (V3) 
loop which greatly enhances the affinity of gp120 to chemokine co-receptors CCR5 or CXCR4. Viral 
tropism is determined by V3-loop recognition of these co-receptors (61, 62). Notably, viral transmission 
independent of co-receptor use has been demonstrated on rare occasions, and the establishment of an 
acute in vivo infection by virus with a mutation in the gp120 V3 loop that prevented its binding with 
CCR5 and/or CXCR4 has been described (63). Evidence of cell-to-cell HIV transmission activated by 
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contact of infected and uninfected primary CD4+ T cells in the absence of an appropriate co-receptor also 
has been reported (64). Conversely, in the CNS, gp120 binding to both CCR5 and CXCR4 co-receptors 
independent of CD4 binding has been documented (65, 66). While these represent instances of CD4/co- 
receptor-independent mechanisms of HIV transmission, it remains that most productive HIV infections 
are mediated by gp120 binding to both CD4 and co-receptors. Indeed, a “low-CD4” entry phenotype, 
characterized by gp120 capable of infecting cells expressing low densities of CD4, have been 
preferentially detected in the CSF of people with HIV-associated dementia. This may be suggestive of 
viral adaptation to the local cellular environment of the CNS allowing virus to infect a population of cells 
expressing lower densities of CD4 (67) .
Distinct strains of HIV can be categorized on the basis of cellular tropism tied to co-receptor 
preferences. Macrophage tropic (R5) strains bind CCR5 receptors and preferentially infect peripheral 
blood mononuclear cells (PBMC), monocytes, macrophages, and T-lymphocytes, but not T-cell lines. T- 
cell tropic (X4) strains bind CXCR4 receptors of T-lymphocytes and T-cell lines, and dual-tropic (R5X4) 
strains bind both CCR5 and CXCR4 receptors (68). Whereas R5 strains are detected throughout all stages 
of infection and disease, the population of viral strains in an individual often evolves during the course of 
infection, and an initial predominance of R5 strains gives way to the emergence of R5X4 and X4 strains 
in an estimated 50% of individuals as infection progresses (69).
The selective pressures driving the switch from CCR5 to CXCR4 receptor usage by HIV are not 
well understood, though there is evidence to support different hypotheses which may explain the 
underlying mechanisms. One hypothesis posits that the emergence of CXCR4-binding virus results from 
a depletion of susceptible CCR5-positive target cells as infection proceeds. This hypothesis is supported 
by data indicating infected individuals heterozygous for a 32 base-pair deletion in the CCR5 gene, which 
results in lower expression of CCR5, have higher incidence of X4 viruses when compared to infected 
individuals with normal CCR5 expression levels (70, 71). Alternatively, a 2016 study provides evidence 
for host humoral immune pressure selecting against CCR5 variants facilitating the emergence of CXCR4 
utilizing virus (72). Although the mechanisms of tropism switch may not be clear, the switch in receptor 
usage has demonstrable clinical implications and the emergence of X4 strains have been linked to more 
severe illness and a more rapid progression to AIDS (73).
Feline immunodeficiency virus (FIV) represents an animal model of immunodeficiency with 
similarities in pathogenesis to HIV infection in humans, including subsequent FIV infection of the CNS 
in domestic cats that results in neurological symptoms comparable to those observed in HAND (74). A 
recently published study investigating the role of FIV envelope glycoprotein gp95-mediated synaptic 
dysfunction found gp95 signaling through neuronal CXCR4 facilitates an elevation in intracellular Ca2+ 
and subsequent increase in synaptic activity (75). Notably, the use of HIV antiretroviral drugs on FIV 
5
infected cats has been demonstrated to significantly reduce viral load, which may be suggestive of a 
similar mechanism for neuropathogenesis between the two lentiviruses, lending further support to a role 
for CXCR4 signaling in HIV neurotoxicity (76, 77).
1.2.3 Gp120 neurotropism
Most cell types in the CNS express HIV target receptors CD4, CXCR4, and CCR5, suggesting 
that virus invading the CNS has the potential to infect many different cell types. CD4 and CXCR4 
receptors have been detected on astrocytes, microglial cells, and neurons. CCR5 expression has been 
predominantly found on astrocytes and microglial cells, with less consistent evidence to support CCR5 
expression on neurons.
Immunohistochemistry and flow cytometry have been used to demonstrate expression of CCR5 
receptors on neurons of macaques and humans and in particular, on hippocampal neurons of patients with 
AIDS (71, 72). Notably, neuronal expression of the receptor was decreased in the brains of AIDS patients 
with HIV encephalitis as compared to AIDS patients without HAND (78, 79). In contrast, 
immunohistochemical analysis of the expression of CCR5, CXCR4, and several other chemokine 
receptors in brains of AIDS-positive and AIDS-negative patients found only CXCR4 expression on 
neurons whereas CCR5 expression was restricted to glial cells (80). These results are in accordance with 
those of several other studies reporting CCR5 expression is restricted to glial cells of the CNS (81-83). 
Whether the purported differences in neuronal CCR5 expression are the consequence of differences in 
experimental approaches or representative of true physiological differences in receptor expression has yet 
to be determined. There is some indication that expression of chemokine receptors in cells of the CNS is 
dependent on cell culture conditions and the cytokine environment. Interestingly, a study of CCR5 
expression in rhesus macaque brains found expression of receptors on cortical neurons increased with age 
and demonstrated differential expression in subpopulations of neuronal cells (84, 85). Such dynamic 
receptor expression may be a factor in the inconsistencies reported above.
Though HIV co-receptors CCR5 and CXCR4 are widely expressed on cells of the CNS, 
productive infection appears to be restricted to microglia and macrophages, although limited latent 
infection of astrocytes has been demonstrated (86-89). Productive infection of neurons has been reported 
but remains rarely observed (90, 91).
1.2.4 Mechanisms of CNS dysfunction
Despite limited evidence supporting direct infection of neurons, it remains that synaptic 
dysfunction and neuronal cell death are prominent features of HAND and likely underlie the cognitive 
and motor dysfunctions exhibited by infected individuals (92-94). Many studies investigating the 
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mechanisms by which HIV impedes CNS function focus largely on neuronal cell death, which is 
attributed to both direct neurotoxic effects of soluble HIV proteins shed from infected cells, as well as 
bystander damage The latter is a consequence of activated macrophages, microglia, and astrocytes 
releasing pro-inflammatory cytokines and chemokines leading to perturbed neuronal homeostasis (95-99). 
While neuronal loss explains some degree of reported neurological complications of infection, neuronal 
death alone does not account for the cognitive impairments observed in HAND (100, 101). HAND has 
been linked to impaired neuronal plasticity, characterized by synaptodendritic damage and decreased 
synaptic and dendritic density. Given the reduction of the severity of HAND, and in some instances the 
partial reversal of HAND symptoms, following initiation of cART, it is likely that a loss of synaptic 
plasticity and synaptodendritic injury account for much of the neuronal pathology observed in the HIV 
infected brain (102). Indeed, synaptic dysfunction is emerging as an important neuropathologic 
mechanism underlying early CNS deficits and a role for several HIV proteins has been implicated in 
synaptic loss (75, 103, 104).
As previously described, FIV envelope protein gp95 has been implicated in CXCR4-mediated 
synaptic dysregulation. In this model, intracellular Ca2+ increase is facilitated by the activation of both 
endoplasmic reticulum (ER) associated calcium channels and inositol triphosphate receptors (IP3Rs), and 
similarly to gp120, the activation of synaptic NMDARs. Notably, the neuronal nitric oxide synthase 
(nNOS)-cGMP pathway was found to be activated by both FIV gp95 and HIV gp120 stimulation of 
NMDARs. Gp95/gp120 interaction with CXCR4 promotes IP3 production and the nNOS induced 
activation of cGMP-dependent protein kinase II (cGKII). Subsequent phosphorylation of IP3Rs and 
serine 845 of AMPA receptor subunit GluA1 by cGKII leads to elevated intracellular Ca2+ levels and the 
promotion of AMPA receptor expression at the cell surface resulting in increased synaptic activity and 
Ca2+ hyperexcitation (75).
Gp120 is among the most potent HIV neurotoxins with deleterious effects reported in vitro for 
concentrations ranging from 1 pM to 1 uM (105, 106). Such potency, in the picomolar and nanomolar 
range in an in vitro model is generally indicative of true in vivo biological relevance. There has been some 
controversy regarding the physiological relevance of gp120 concentrations used in vitro to extrapolate its 
in vivo effects. Early attempts to quantify gp120 concentrations in vivo relied on capture enzyme­
immunoassays which may be influenced by interfering plasma antibodies or limitations in the specificity 
of the detecting antibody (106-108). While current understanding of in vivo concentrations of soluble 
gp120, particularly in the CNS, remains unclear, there is substantial evidence for a pool of soluble gp120 
that has biological activity independent of productive infection (43). Indeed, in vitro and in vivo studies 
have demonstrated gp120-mediated cell death in various neuronal populations and the resulting neuronal 
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and synaptic loss, axonal retraction and dendritic simplification are similar to neuropathy observed in 
postmortem brains of HAD subjects (109, 110).
1.2.5 Gp120-mediated neuronal apoptosis
Several studies have identified a role for enhanced N-methyl-d-aspartate receptor (NMDAR) 
activation in gp120-mediated neurotoxicity. NMDA receptors are widely expressed on neurons and 
enhanced activation of NMDAR by high concentrations of endogenous glutamate results in the rapid 
influx of Ca2+ and free radical generation, ultimately activating pathways leading to neuronal apoptosis 
(110, 111). Chronic NMDAR mediated excitotoxicity has been implicated in several neurodegenerative 
diseases including Alzheimer's disease and Huntington's disease and excitotoxicity in HAND has been 
linked to the gp120-induced release of excitatory molecules, including glutamate, from activated 
microglia and astrocytes in the CNS (89, 112-114). Interestingly, gp120 has also been shown to act 
directly on NMDA receptors via interaction of gp120 V3 loop to the glycine site of the receptor and may 
be indicative of direct mechanisms of neurotoxicity induced by gp120 interaction with NMDA receptors 
(115).
In addition to NMDAR mediated neurotoxicity, gp120 has been associated with the generation of 
reactive oxygen species (ROS) and nitrosative stress which are potentially toxic for neurons. Astrocyte 
exposure to gp120 led to production of ROS and tumor necrosis factor-alpha (TNF-α) in N9 murine 
microglial cells and stimulated upregulation of inducible nitric oxide synthase (iNOS), an important 
source of nitric oxide (NO) and nitrosative stress (116, 117). In these indirect models of gp120 
neurotoxicity, release of excitotoxic mediators from surrounding macrophages and glial cells induces 
neuronal apoptosis via disruption of neuronal homeostasis. These results suggest that mitigating oxidative 
stress in HAND through the use of antioxidants to protect against neuronal apoptosis arising from indirect 
insults mediated by gp120 might be effective therapy, and several studies have investigated this approach 
with varying degrees of success (117, 118). Gp120 may also act directly on neurons to enhance NMDA- 
evoked calcium flux, possibly via modifications in spatial localization and focal density of NMDA 
receptors to lipid raft domains (119). Gp120 has also been demonstrated to induce activation of nNOS 
directly in neurons, representing another potential source of NO and nitrosative stress, as well as a 
possible mediator of calcium hyperactivity and resulting synaptic dysregulation (75, 120).
Notably, neurotoxic effects of gp120 in the absence of NMDAR activation or production of 
inflammatory cytokines has been demonstrated. In the absence of productive viral infection of neurons, 
soluble gp120 in the CNS can induce neurotoxicity via direct interaction with chemokine receptors 
expressed on neuronal surfaces (121). Gp120 induced cell death in human neuroblastoma cells through 
direct interaction with both neuronal CXCR4 and CCR5 chemokine receptors (122). Further support for 
8
the role of chemokine receptors in mediating gp120 neurotoxicity comes from the discovery that 
endogenous chemokines are capable of blocking gp120-induced apoptosis of hippocampal neurons (123). 
Interestingly, while endogenous CCR5 ligands, including macrophage inflammatory protein (MIP)1α, 
MIP-1β, and ‘regulated-and-normal-T cell-expressed and secreted' RANTES have been shown to slow 
progression to AIDS, the CXCR4 endogenous ligand SDF-1α has been demonstrated to induce neuronal 
apoptosis in some populations of cells following binding of the CXCR4 receptor (124, 125). It should be 
noted that the majority of viruses isolated from the CNS are R5 strains, while R5X4 and X4 binding 
variants occur less frequently (126, 127). Despite this, signaling through CXCR4 has been identified as an 
important pathway in gp120-induced neuronal apoptosis (2, 128).
1.2.6 Gp120-induced synaptic and dendritic dysfunction
Synaptodendritic damage has emerged as a hallmark of HIV infection of the CNS, and several 
groups have reported a role for gp120 in synaptic dysfunction and dendritic simplification observed in 
HAND. An early neuro-histological assessment of synaptic and dendritic markers identified a strong 
correlation between presynaptic and neocortical dendritic damage and abundance of gp120 in neocortical 
gray and deep white matter (129). The authors posit that in this model of neurotoxicity, glutamate 
signaling through NMDA receptors on dendritic membranes is a likely contributor to the observed 
pathology. Gp120 was similarly found to induce significant loss of synaptic connectivity in hippocampal 
neurons in the absence of neuronal apoptosis via an indirect mechanism involving the activation of 
NMDA and CXCR4 receptors, and requiring the release of cytokines from non-neuronal cells (130). 
Gp120 was further found to induce gliosis and neuronal dendritic injury in a primary mixed human CNS 
culture analogous to dendritic injuries observed in post-mortem brains of HIV infected individuals (131).
Subsequently, there is evidence suggesting that gp120 neurotoxicity is the result of spatially 
distinct mechanisms. In an investigation of HIV-associated sensory neuropathy, gp120- mediated axonal 
degeneration in rat spinal dorsal root ganglia (DRG) occurred as a result of two independent mechanisms 
(132). Prominent axonal toxicity in the absence of apoptosis was observed only when gp120 was applied 
directly to sensory axons, with no effect when applied to cell bodies. Conversely, gp120 mediated 
neuronal apoptosis and subsequent axonal degeneration was found to be dependent on the activation of 
Schwann cells. Notably, gp120-induced direct axonal degeneration was found to be dependent on the 
local activation of the caspase pathway and mediated by activation of both CXCR4 and CCR5 receptors 
(132). Blocking the CXCR4 receptor by monoclonal antibody prevented gp120-induced axonal toxicity 
and partial prevention of toxicity occurred by blocking the CCR5 receptor. These results highlight an 
intriguing mechanism by which axonal degeneration following direct gp120 exposure occurs
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independently of toxicity in neuronal cell bodies.
1.3 Raft-associated signaling
Membrane lipid raft domains have been demonstrated to be critical sites of interaction between 
gp120 and chemokine receptors, mediating both internalization of the viral protein and activation of 
pathways contributing to apoptosis (Figure 1.2) (133, 134). Lipid rafts also appear to be necessary for 
appropriate receptor conformation to support CXCR4-chemokine binding (135). Gp120 coupled to 
CXCR4 in primary neurons induces neuronal apoptosis via activation of the sphingomyelin-catabolizing 
enzyme neutral sphingomyelinase (NSmase) (134). In this pathway, activation of NSmase is regulated by 
the NADPH-oxidase (NOX2)-mediated production of superoxide radicals in neurons, leading to the 
increased production of ceramide, an apoptotic second messenger in a number of cell types including glia 
and neurons. SDF-1 was also found to induce neuronal apoptosis through the same NSmase-mediated 
pathway, confirming a role for CXCR4 in this pathway of pathologic signal transduction (134).
While overproduction of ceramide has previously been linked to neurotoxicity, ceramide is an 
important component of cellular lipid raft domains (136). Experiments have demonstrated coalescence of 
lipid raft domains into larger platforms following ceramide generation by sphingomyelinases (137). 
Gp120 binding to cellular receptors has been demonstrated to similarly induce lipid raft coalescence, 
leading to the increased size and stability of raft domains (119). Raft coalescence has been proposed as a 
mechanism for clustering receptors and components of receptor-activated signaling cascades, and gp120- 
induced raft coalescence in hippocampal neurons has been found to promote the forward trafficking and 
surface clustering of NMDA receptors in rafts in a CXCR4 dependent manner (119, 138). Prolonged 
surface clustering of NMDA receptors in lipid raft domains of neurons may represent an additional 
mechanism of gp120 mediated neurotoxicity via perturbation of intracellular Ca2+ flux or associated 
signaling events.
Notably, profound changes in lipid rafts are observed for a number of CNS dysfunctions, 
including Alzheimer's disease, mild cognitive impairments (MCI), CNS aging, and CNS trauma (49, 139­
142). Biophysical properties of lipid rafts are imperative for their signaling capacities and even subtle 
changes in lipid species rapidly affect overall membrane architecture influencing the structure and 
function of membrane proteins (143-147). Presumably, entire signaling cascades could be silenced due to 
imposed constraints on lipid-protein and/or protein-protein interactions. Emerging evidence attributes 
cholesterol a ‘chaperone-like' allosteric function in stabilizing structural elements of many membrane 
proteins through a Cholesterol Recognition/Interaction Amino Acid Consensus sequence or CRAC motif 
(-L/V-X(1-5)-Y/F-X(1-5)-R/K-) or its reverse sequence (CARC motif) (148-153). This sequence establishes 
interaction with the isooctyl tail (A, L, and V), the sterol ring structure (Y, F), and the 3β-OH group (R,K) 
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of cholesterol. Spatiotemporal alterations of protein function by cholesterol interactions was demonstrated 
for neurotransmitter receptors (nAchR, 5-HT2B), CXCR4, the β-adrenergic receptor, Na+K+-ATPase, and 
the C99 domain of amyloid-precursor protein (APP) implicated in promoting the amyloidogenic pathway 
(58, 150, 152). Aberrations in cholesterol homeostasis are commonly associated with degenerative CNS 
diseases including AD and MCI.
1.4 Cofilin-Actin Rods: A potential mechanism for gp120-mediated synaptic dysfunction
Protein association with lipid rafts as a mechanism for regulating signaling has been seen in a 
number of neurodegenerative diseases, most notably in Alzheimer's disease, where lipid raft-anchored 
cellular prion protein PrPC serves as a receptor for amyloid-! (A!) oligomers (154, 155). Previous 
research has identified a pathway mediated by ROS generation and NOX leading to the formation of 
cofilin-actin bundles (rods) initiated by the binding of diverse extracellular ligands, including 
proinflammatory cytokines and A! to raft localized receptors (154, 156). Generation of rod-like 
inclusions is a cellular response to oxidative stress conditions and is characterized by the local 
dephosphorylation (activation) of cofilin and subsequent assembly of 1:1 cofilin:actin filaments that 
bundle into rod-like structures containing intermolecular disulfide cross-linked cofilin (157). Rod 
formation may be a transient response to oxidative stress and rods can dissociate following relief from 
oxidative stress. Rod formation might also be responsible for the loss of synaptic function and decreased 
network connectivity observed in many neurodegenerative conditions including HAND (158, 159). 
Although actin rod formation has not been identified in FIV in vitro or in vivo, considerable disruption to 
the neuronal cytoskeleton has been demonstrated both for filamentous actin structures as well as 
microtubule structures (161).
Indeed, cofilin sequestration into rods might have a neuroprotective effect due to its ability to 
promote mitochondrial-dependent apoptosis through its oxidation to form intramolecular disulfide bonds 
and its ability to target the tumor suppressor protein p53 to the nucleus and mitochondrion (160, 161). 
However, persistent rods have been described in neurons during the progression of Alzheimer's and other 
neurodegenerative disease (162). Cofilin-actin rods have also been observed in brains of AD model mice 
where their decreased abundance through inhibition of cofilin dephosphorylation or reduced cofilin 
expression results in normalizing cognitive function and long-term potentiation in brain slice cultures 
(163, 164). In addition to synapse loss due to interrupted vesicular transport resulting from occlusion of 
neurites in which rods form, cofilin-actin rods have been linked to synaptic dysfunction via sequestration 
of cofilin from dendritic spines where it plays an important role in post-synaptic plasticity associated with 
learning and memory (165, 166). Normalization of cofilin activity in dendritic spines through modulation 
of upstream kinases and phosphatases by cell penetrating peptides has proven to be effective in many 
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different neurological disorders, including AD (167). Aβ induction of cofilin-actin rods requires the 
expression of cellular prion protein PrPC in raft domains and is mediated by ROS generation by NOX 
(154).
A number of intriguing commonalities in the neuronal response to HIV gp120 stimulation and 
that of Alzheimer's associated protein Aβ have been identified, among them the enhanced lipid raft 
coalescence into stable macro domains, the activation of NMDA receptors localized to lipid rafts, and the 
NOX2 mediated generation of ROS (49, 119, 134). Given these commonalities, it is quite likely that 
gp120 mediated stimulation of NOX2 also leads to the downstream formation of cofilin rods, thereby 
inducing synaptic loss and impaired synaptic function similar to what occurs in other neurodegenerative 
diseases such as Alzheimer's. Interestingly, gp120-mediated CXCR4 signaling has been demonstrated to 
activate cofilin in resting T-cells as a mechanism of facilitating nuclear localization and replication of the 
virus (168). Rods have also been demonstrated to be induced by nitric oxide, a source of oxidative stress 
shown to be generated by both HIV gp120 and FIV gp95 via CXCR4 mediated signaling (75). Further 
supporting the role of cofilin-actin rods in HIV-mediated synaptic dysfunction, data generated in our lab 
has shown gp120 is capable of inducing rod formation in rat E18 hippocampal neurons via CXCR4 - 
associated signaling. Similarly to rod induction by Aβ, this pathway appears to be mediated by the 
presence of PrPC in membrane raft domains (Smith et al., in preparation.).
Demonstrating the pivotal role of cholesterol as a “chaperone” allosteric modulator of NOX2- 
dependent superoxide generation would considerably advance our understanding of how membrane 
architecture regulates protein structure and function, potentially identifying putative interaction surfaces 
of NOX2 with cholesterol possibly through CRAC/CARC motifs and provide detailed insight into 
structure/function aspects of NOX2. Exploiting these findings could open new avenues for drug­
discovery approaches to target NOX as well as novel therapeutic strategies to ameliorate gp120-induced 
oxidative stress in the CNS. Entire signaling networks could presumably be silenced by interference with 
annular lipids, boundary lipids, activating lipids, and/or “chaperone” lipids (146, 147, 169-171).
1.5 Research objectives
Despite the reduction in incidence of severe forms of HAND, prevalence of milder forms is 
expected to increase with the aging population of HIV-infected individuals independent of adherence to 
cART, representing a significant public health challenge. Gp120-associated receptor binding and 
activation of NOX2-mediated oxidative stress has identified a potential mechanism linking gp120- 
CXCR4/CCR5-induced ROS formation to pathways of early synaptic dysfunction characteristic of 
HAND and many other neurodegenerative diseases including Alzheimer's and Parkinson's diseases. The 
main objective of this dissertation is to determine the role of gp120 and co-receptor tropism in the 
12
induction of pathologic neuronal cofilin-actin rods in three model systems: rodent derived primary 
neurons, human neuroblastoma cells, and human embryonic stem cell derived neurons. The research 
approach focused on the following aims:
1.5.1 Aim 1: What are the consequences of distinct gp120 co-receptor tropism on the generation of rod­
like cofilin-actin inclusions in primary rodent neurons (Figure 1.3)?
Preliminary experiments in our lab revealed dual tropic gp120 induced the formation of cofilin­
actin rod like structures in distal neurites of primary rodent neurons. This study aimed to further delineate 
the roles of the individual chemokine co-receptors CXCR4 and CCR5 in the generation of rods and their 
part in the activation of a previously described molecular pathway leading to rod formation. These studies 
identified a molecular pathway leading to neuronal rod formation requiring both active NOX and 
expression of the cellular prion protein (PrPc) that is initiated by the binding of a number of extracellular 
ligands, including the Alzheimer's associated Aβ oligomers and proinflammatory cytokines. Given that 
Alzheimer's disease and HAND are both characterized by oxidative stress and neuroinflammation, we 
tested the hypothesis that gp120 binding to chemokine co-receptors CXCR4 and/or CCR5 induces 
formation of rods in a NOX-PrPC dependent manner by exposing E16.5 mouse hippocampal neurons to 
three different gp120 strains— dual-tropic, R5-tropic, and X4-tropic gp120. The results from this study 
provide evidence for gp120 induced actin-cofilin rod formation through the PrPC/NOX2 signaling 
pathway as a previously unknown mechanism of early synaptic dysfunction in HAND.
1.5.2 Aim 2: Does gp120 stimulate lipid raft coalescence, NOX-mediated generation of ROS, and 
cofilin-actin rod formation in SH-SY5Y human neuroblastoma cells (Figure 1.4)?
Current in vivo models for investigating rod formation rely on the use of murine primary neurons, 
owing to the expense and ethical issues involved in the use of primary neurons of human origin. Neuronal 
models of HAND also frequently rely on the use of cells of nonhuman origins. As HIV naturally infects 
only humans, we sought to investigate the role of gp120 in the activation of lipid raft coalescence and 
induction of oxidative stress and rod formation in a more physiologically relevant model system. Utilizing 
SH-SY5Y human neuroblastoma cells we assessed the effects of gp120 exposure on undifferentiated and 
differentiated cells. Given an absence of distinct neuronal processes, undifferentiated SH-SY5Y cells 
cannot be used to evaluate rod formation downstream of gp120/receptor interactions. However, SH-SY5Y 
cells can be terminally differentiated to express long, branched neuronal processes and markers of mature 
neurons. In this study, SH-SY5Y cells were differentiated to examine gp120/co-receptor mediated rod 
formation. The results of this study found that gp120-induces lipid raft coalescence and the NOX- 
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mediated generation of ROS, providing evidence for gp120-mediated neurotoxicity. Differentiated SH- 
SY5Y cells were further evaluated as a non-murine model for rod formation.
1.5.3 Aim 3: Can mature human neurons derived from embryonic stem cell (hESc) serve as a more 
relevant model for the investigation of gp120 induced actin-cofilin rods (Figure 1.5)?
While SH-SY5Y cells are a widely used model in the investigation of HAND, results obtained 
from the use of immortalized cell lines may not be necessarily representative of primary human neurons. 
These immortalized cells often exhibit intracellular regulations that differ from primary human neurons 
and may have accumulated mutations as a consequence of numerous replications. Previous studies 
demonstrate that the responses of primary neurons and immortalized neuronal cultures differ in their 
sensitivities to toxins and the exhibit differential expression of membrane receptors (172, 173). To 
overcome these limitations and move closer towards a truly physiologically relevant model for the 
investigation of HAND, we sought to establish a protocol for the direct induction of mature, cortical 
human neurons derived from hESc and evaluate these induced neurons for gp120 mediated rod formation. 
The results from this study will provide the basis of future studies to investigate the role of gp120 and co­
receptors in HAND in a primary neuronal population of human origin.
14
1.6. Figures and Tables
Figure 1.1. Schematic representation of HIV-1 surface proteins gp120 binding to host cell receptors in 
lipid raft domains. A. Viral membrane bound gp41/gp120 trimers. B. Binding to cellular CD4 receptor 
facilitates a conformational change in gp120 variable loop 3, allowing for further interaction with 
chemokine co-receptors CCr5 or CXCR4 (C).
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Figure 1.2. Schematic diagram illustrating neurotoxic effects of soluble gp120 interactions with neuronal 
receptors. Direct interaction of gp120 with both chemokine co-receptors CCR5 and CXCR45, as well as 
N-methyl-D-aspartate (NMDA) receptors on neuronal surfaces leads to increased generation of reactive 
oxygen species and intracellular calcium influx, and the activation of signaling pathways leading to 
cellular apoptosis. In the absence of apoptosis, gp120 has been demonstrated to induce dendritic and 
axonal degeneration leading to a loss of neuronal connectivity and formation of actin-cofilin rods.
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Chapter 2: Direct Interaction of HIV gp120 with Neuronal CXCR4 and CCR5 Receptors Induces 
Cofilin-Actin Rod Pathology via a Cellular Prion Protein- and NOX-Dependent Mechanism
Figure 1.3. Dissertation Chapter 2 Graphical Abstract
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Figure 1.4. Dissertation Chapter 3 Graphical Abstract
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Figure 1.5. Dissertation Chapter 4 Graphical Abstract
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Chapter 2: Direct Interaction of HIV gp120 with Neuronal CXCR4 and CCR5 Receptors Induces Cofilin 
Actin Rod Pathology via a Cellular Prion Protein- and NOX2-Dependent Mechanism
2.1 Abstract
Nearly 50% of individuals with long-term HIV infection are affected by the onset of progressive 
HIV-associated neurocognitive disorders (HAND). HIV infiltrates the central nervous system (CNS) early 
during primary infection where it establishes persistent infection in microglia (resident macrophages) and 
astrocytes that in turn release inflammatory cytokines, small neurotoxic mediators, and viral proteins. 
While the molecular mechanisms underlying pathology in HAND remain poorly understood, 
synaptodendritic damage has emerged as a hallmark of HIV infection of the CNS. Here, we report that the 
viral envelope glycoprotein gp120 induces the formation of aberrant, rod-shaped cofilin-actin inclusions 
(rods) in E16.5 mouse hippocampal neurons via a signaling pathway common to other neurodegenerative 
stimuli including oligomeric, soluble amyloid-β and proinflammatory cytokines. Synaptic function is 
impaired preferentially in the distal proximity of rods within dendrites. Our studies demonstrate gp120 
binding to either chemokine co-receptor CCR5 or CXCR4 is capable of inducing rod formation and 
signaling through this pathway requires active NADPH oxidase, presumably through the formation of 
superoxide (O2-) and the expression of cellular prion protein (PrPC). These findings link gp120-mediated 
oxidative stress to the generation of rods, which may underly early synaptic dysfunction observed in 
HAND.
2.2 Introduction
HIV infection of the CNS is characterized by the induction of inflammatory and neurotoxic 
insults, including the activation of microglia and astrocytes, suspected to stimulate a progressive synaptic 
degeneration manifested in cognitive decline. Despite the prevalence of HIV-associated neurocognitive 
disorders (HAND) the underlying molecular and cellular mechanisms promoting pathogenesis remain 
poorly understood but are thought to consist of a combination of direct viral infection of the cells of the 
CNS and indirect neurotoxicity mediated by inflammatory cytokines, metabolites, and effects of viral 
proteins including the envelope glycoprotein gp120. Gp120 is a potent neurotoxin with roles in a number 
of indirect and direct neurotoxic pathways including the release of excitatory molecules, reactive oxygen 
species (ROS), and pro-inflammatory cytokines from activated microglia and astrocytes (indirect) as well
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as NMDAR mediated excitotoxicity and co-receptor mediated neuronal apoptosis arising from the direct 
interaction of gp120 with receptors expressed on the neuronal membrane (Lipton et al., 1991; Bell, 1998; 
Kaul et al., 2001; Chen et al., 2002; Wang et al., 2003; Lewerenz and Maher, 2015).
Gp120 facilitates viral entry to host cells via its interaction with primary host-cell receptor CD4 
and chemokine co-receptors CCR5 and CXCR4 at host-cell lipid raft domains (Kozak et al., 2002). 
Gp120 co-receptor preference categorizes distinct strains of HIV on the basis of cellular tropism, with 
macrophage tropic (R5) strains binding CCR5 receptors, T-cell tropic (X4) strains preferentially binding 
CXCR4 receptors, and dual-tropic (R5/X4) strains binding both co-receptors (Wilen et al., 2012). Binding 
of gp120 to cellular receptors induces coalescence of lipid raft domains into large, stable platforms— a 
proposed mechanism for clustering receptors and components of receptor-activated signaling cascades 
observed in a number of CNS dysfunctions, including CNS aging and trauma, as well as Alzheimer's 
disease (Jana and Pahan, 2004). Indeed, gp120 was found to enlarge and stabilize raft domains in a 
CXCR4-dependent pathway involving the redox-sensitive translocation of neutralsphingomyelinase 2 
(nSmase2) to the membrane and the forward trafficking, surface expression, and clustering of NMDA 
receptors to enlarged raft domains (Cremesti et al., 2002; Jana and Pahan, 2004). These studies are 
consistent with macrodomain formation promoted by the release of ceramide from nSmase2-mediated 
hydrolysis of sphingomyelin to activate signaling in response to various agonists and stress signals. 
Specifically, a redox-sensitive translocation of nSmase 2 is mediated by the gp120 stimulating a lipid-raft 
localized NADPH-oxidase 2 (NOX2) with a subsequent production of superoxide (O2-) radicals in 
neurons (Jana and Pahan, 2004).
The interaction of proteins with lipid-raft localized receptors as a mechanism of regulating 
pathologic signaling has been observed for a number of neurodegenerative diseases, most notably in 
Alzheimer's disease where soluble, stable amyloid-β dimers and trimers (Aβ d/t) interact with the lipid 
raft-anchored cellular prion protein PrPC to stimulate a pathway mediated by activated NOX leading to 
the formation of rod-shaped bundles of filaments composed of a 1:1 complex of cofilin-actin (Iskander et 
al., 2004; Bamburg et al., 2010; Minamide et al., 2010; Walsh et al., 2014). These rod-like inclusions are 
generated in response to oxidative stress conditions and arise from the oxidation of active (dephospho) 
cofilin in stressed neurons to form intermolecular disulfide cross-linked cofilin (Bernstein et al., 2012). 
Rods have been described during the progression of Alzheimer's and other neurodegenerative diseases 
where they contribute to cytoskeletal abnormalities and synaptic dysfunction through the disruption of 
normal actin dynamic, the blocking of neuronal transport, and the sequestration of cofilin from dendritic 
spines resulting in dendritic simplification (Minamide et al., 2000a; Maloney et al., 2005; Gu et al., 2010; 
Cichon et al., 2012; Rahman et al., 2014).
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Given the similarities in the neuronal response to HIV gp120 and that of Aβ d/t it is feasible that 
gp120-sensitive production of O2- mediated by NOX2 is similarly inducing the downstream formation of 
cofilin-actin rods. Here, we provide evidence that gp120 signaling through chemokine co-receptors CCR5 
and CXCR4 induces the formation of cofilin-actin rods via a pathway common to AβdΛ and 
proinflammatory cytokines comprised of PrPC and NOX2.
2.3. Methods
2.3.1. Ethics Statement
All animals were handled according to the guidelines provided by the National Research Council 
for the Care and Use of Laboratory Animals as approved by the Colorado State University Institutional 
Animal Care and Use Committee (IACUC approved protocol #17-7411A).
2.3.2. Reagents
All chemical reagents were obtained from Sigma-Aldrich Co. (St. Louis, MO) unless indicated 
otherwise. Tissue culture reagents and immunocytochemistry reagents were from ThermoFisher 
(Waltham, MA). Primary antibodies used are: rabbit anti-cofilin antibody (2 ng/mL, affinity 
purified)(rabbit 1439, (Shaw et al., 2004); mouse monoclonal actin antibody (C4; XXXXX); rabbit anti- 
CXCR4 (NIH AIDS Reagent Database, Catalogue #11232; 1:250 dilution); rabbit anti-CCR5 (NIH AIDS 
Reagent Database, Catalogue #11236),; rabbit monoclonal antibody to microglia (Iba-1, Abcam 178846) 
a generous gift from Dr. R.A. Swanson, UCSF; and mouse monoclonal antibody to glial fibrillary acidic 
protein (GFAP) (Fisher Sci., MA5-15086). Dual-tropic gp120MN and X4-tropic gp120IIIB were obtained 
from Immunodx (Woburn, MA). For R5-tropic strains gp120CM was obtained from ProSpec Proteins 
(Ness-Ziona, Israel) and gp120BaL was obtained from NIH AIDS Reagent Database (Catalogue #4961).
2.3.3. Source of neurons
Mouse neurons were obtained from either wildtype C57BL/6, PrPC null (C57BL/6J-Prnp-/-; 
Talen) or p47PHOX null (B6N.129S2-Ncf1tm1Shl/J p47phox -/-; JAX 027331) lines. Rat neurons were 
from Sprague-Dawley rats.
2.3.4. Neuronal cell culture
Hippocampal and cortical neuron cultures were prepared either from freshly dissected from E16.5 
fetal mouse or E18 fetal rat brains according to the method of Barlett and Banker or from cell stocks of 
these dissociated neurons frozen at 106 cells/ml (hippocampal neurons) or 107 cells/ml (cortical neurons) 
in 50% Fetal bovine serum (FBS) and self-made Neurobasal medium (sfNB, see below). Briefly, round 
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glass cover slips (12 mm diameter, #1 German, Carolina Biologicals Supply Co.) inserted into 24 well 
plates were coated with 100 mg/ml poly-D-lysine (30 min, RT), washed 3 times with ultrapure water, and 
air. Dissociated neurons were plated at a density of 40,000 neurons per well (0.5 ml medium per well) in 
10% FBS (Hyclone, VWR Radnor, PA)-supplemented complete growth medium composed of self-made 
Neurobasal (sfNB) (made from all component of commercial NB but with highly purified L-serine and 
adjusted to final concentrations of 175 μM L-cysteine, 2.5 mM glucose and to 300 mOsM with NaCl), 
Glutamax used at 25 μl∕10 ml, 50 U/ml penicillin, 50ug∕ml streptomycin, N21-MAX (R&D Systems) at 
1ml/50ml. Cultures are incubated at 37°C in a humidified incubator with 5% CO2). After 1 to 2 h, serum­
containing medium was removed, replaced with complete growth medium (1 ml/well) and exchanged 
every 3 days.
2.3.5. Adenovirus preparation
Recombinant, replication deficient adenovirus for the expression of EGFP-PrPc, lacZ-GFP, and 
DNp22PHOX (a dominant negative from of the small membrane NOX subunit p22PHOX) were made using 
the AdEasy system (He et al., 1998; Minamide et al., 2003). Virus titer was determined by 
immunostaining against E2A of infected HEK293 cells as previously described (Minamide et al., 2003). 
Titers were expressed as focus-forming units (ffu/ml) and were usually about 109 ffu/ml. Recombinant 
adenoviruses were stored at -80oC.
2.3.6. Adenovirus infection of neurons
Replication deficient, recombinant adenovirus was added to neurons 4 days after plating (days in 
vitro, DIV) at 30 to 200 multiplicity-of-infection (MOI) to express either EGPF-PrPc, lacZ-GFP, or 
DNp22PHOX. Infection was executed concomitant with a full medium exchange.
2.3.7. Rod induction in neuronal cultures
Rod induction was initiated at 6 DIV over a time period of 16 h unless indicated otherwise. After 
a complete medium exchange (1ml/well), doses between 250 pM and 750 pM of dual tropic gp120MN, 
monotropic X4 (gp120IIIB) or monotropic R5 (gp120Bal or gp120CM) were added in serum-free sfNB. 
Amyloid beta dimer/trimers (Aβd∕t) were isolated from medium of 7PA2 cells as previously described 
(Walsh et al., 2002; (Cleary et al., 2005; Davis et al., 2011) and used at approximately 1 nM final 




Maraviroc (R5 inhibitor, 100 nM, Santa Cruz Biotechnology), AMD3100 (X4 inhibitor, 50 nM, 
Santa Cruz Biotechnology.) or TG6-227 (NOX inhibitor, kindly provided by Dr. Lambeth) were added to 
some cultures 1 h prior to addition of gp120 and maintained for the duration of the experiment.
2.3.9. Immunolabeling of rods and chemokine receptors
Following treatments, neuronal cultures were fixed in 4% formaldehyde, 0.1% glutarladehyde in 
warm (37oC at addition) phosphate buffered saline (PBS) for 30 min at room temperature. Cultures were 
washed 3 times with PBS and permeabilized with methanol (chilled to -20oC) for 3 min. After several 
washed with Tris buffered saline (TBS), cultures were treated with blocking buffer (5% goat serum, 1% 
BSA in TBS) for 1 h prior to the addition of primary antibodies overnight (4oC). After 3 wash steps with 
TBS, Alexa-488 or Alexa-564 secondary antibodies (1:1000) were applied for 1 h (room temperature), 
followed by 3 washes in TBS, and coverslips were then mounted onto glass slides with ProLong Gold 
Antifade containing DAPI (Molecular Probes, Eugene OR).
2.3.10. Rod quantification
Immunolabeled neurons were imaged on an inverted fluorescence microscope using a 40x air 
objective and scored by an individual blinded to the treatments or by more than one individual. For most 
experiments, at least 100 neurons per coverslip were scored for the presence of rods with triplicates for 
each condition and three independent experiments. Neuronal processes in the vicinity of non-neuronal 
cells and rod-like staining in growth cones were disregarded in the analysis. Scoring in low density 
cultures was performed by calculating the percent of isolated neurons with rods, whereas in higher density 
cultures, rod index was scored by counting the number of rods per total nuclei (DAPI) per field of view.
2.3.11. Statistical analysis
Quantification of all experiments were performed with at least triplicate samples for each 
condition and repeated in at least three independent experiments. For rod analysis, rod index (number of 
rods per neurons in a field of view) and percent neurons with rods were calculated and independent group 
averages (from triplicates) were used to calculate the standard deviations shown on plots. Significant 
differences among treatments and between treatments and controls were tested by one-way ANOVA with 
Tukey's or Dunnett's posthoc-analysis using Graph Pad Prism software (GraphPad Software, Inc.). An 
alpha level of 0.05 was used for all statistical analyses.
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2.4. Results
2.4.1. Gp120 interacts with neurons to induce actin-cofilin rods in a dose- and time-dependent manner
Prior to experiments examining gp120-mediated rod induction, we first addressed the issue of 
spontaneous rod formation in neuronal cultures. Through many years of experiments scoring rods in 
neuronal cultures, untreated controls generally had fewer than 5% of neurons with "spontaneous" rods 
(e.g. Walsh et al., 2014), in recent years this number became much more variable and often exceeded 25%, 
with rods/cell (rod index) of 0.5 to 1.0, totally unacceptable in our experiments. As the increase in 
spontaneous rods is likely due to culture stress, we sought to improve culture conditions to reduce 
spontaneous rods. By using a complete growth medium based on self-made neurobasal (sfNB) media 
made with L-serine purchased from a supplier with low D-serine contamination, low glucose (2.5mM) 
and a physiological osmolarity of 300 mOsM, we reduced sponataneous rods from what we were getting 
with commercial NB to 5% or less and lowered the rod index to less than 0.2 rods/neuron. Neuronal 
cultures were maintained in complete growth medium utilizing sfNB as a basal medium for all 
experiments reported here, with the exception of those examining the role of NOX activity.
Gp120 has been previously demonstrated to be a potent generator of ROS (Walsh et al., 2004; 
Guo et al., 2013; Louboutin and Strayer, 2014). Given the requirement of oxidized cofilin for the 
formation of cofilin:actin rods, we examined whether gp120 is capable of inducing rod formation in 
cultured mouse hippocampal neurons. Neurons at DIV 6 were treated with increasing concentrations of 
dual-tropic gp120MN for 18 hours before being fixed, immunostained for actin and/or cofilin, and 
evaluated for rod formation (Figure 1A). For each concentration tested, dual-tropic gp120 induced rod 
formation significantly (p<.01) above the untreated control in a dose-dependent manner (Figure 1B). As 
dual-tropic gp120 is capable of binding to both R5 and X4 receptors, we further evaluated the ability of 
mono-tropic gp120 strains to induce rod formation. Neurons exposed to increasing concentrations of X4- 
and R5-tropic gp120 (gp120IIIB and gp120CM) for 18 hours demonstrated rod formation significantly 
above control at concentrations of 500 and 750 pM for both strains tested (p£0.03) suggesting that both 
co-receptors are capable of initiating gp120-mediated rod formation (Figure 1B). We next examined the 
time course of dual-tropic gp120 mediated rod formation. Mouse hippocampal neurons were treated with 
500 pM dual-tropic gp120 and the percent of neurons forming rods increased over time, reaching 
significance above control by 6 h (p£0.003) and half-maximum rod induction at 8 to 9 h (Figure 1C). 
Previous studies have demonstrated that almost all neurons can form rods when subjected to energy 
depletion ((Minamide et al., 2000a) but rods are induced in a maximum of 20-25% of cultured mouse 
hippocampal neurons by Aβ d/t and the proinflammatory cytokine TNFa when used separately or in 
combination (Walsh et al., 2014), suggesting that both inducers are eliciting rod formation through the 
same pathway (Walsh et al., 2014).
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To determine if dual-tropic gp120 is also inducing rods through the same pathway, mouse 
hippocampal neurons were treated with 500 pM dual tropic gp120 alone or in conjunction with either 50 
ng/ml TNFα or 1 nM Aβd∕t for 24 h before immunostaining and rod quantification. Rods were observed in 
20-25% of dual-tropic gp120-treated neurons alone or in combination with Aβd∕t or TNFa (Figure 1D). 
Interestingly, we also found dual-tropic gp120-mediated rod formation to be reversible as washing out 
gp120 after a 22 h exposure significantly reduced the percentage of neurons with rods detected 2-hours 
post washout (p<.001) (Figure 1D), similar to what was observed for TNFa-induced rods (Walsh et al., 
2014). We observe similar rod induction by gp120 in mouse cortical neurons (dual-tropic gp120), as well 
as a time-dependent formation of rods in rat cortical neurons with R5 or X4-tropic gp120 (Supplemental 
Figure S2). Notably, in rat cortical neurons, gp120 signaling through CXCR4 appears to be a more potent 
inducer of rod formation. Taken together, these findings suggest that gp120, Aβ d/t, and TNFa all induce 
rod formation in a subpopulation of hippocampal neurons through what is likely a common pathway, and 
that continuous exposure to gp120 is required for the persistence of gp120-induced rods.
2.4.2. Mouse hippocampal neurons express CCR5 and CXCR4 chemokine receptors (R5 and X4)
We next assessed the role of individual co-receptors in the induction of rods. Though most cell 
types in the human CNS express either chemokine receptor, there has been less consistent evidence of R5 
expression on neuronal cells (Bell, 1998; Gabuzda and Wang, 2000; Canto-Nogues et al., 2005; Sorce et 
al., 2011). To confirm that both X4 and R5 are indeed expressed in rodent hippocampal neurons, both 
mouse and rat neurons were cultured to DIV7, fixed, and immunostained for each receptor. Both 
receptors are widely expressed in rodent hippocampal neurons on the soma as well as on all neurites 
(Figure 2A). As levels of R5 expression in mouse neurons have been reported to increase following 
exposure to extrinsic stress insults (Joy et al., 2019), we tested whether gp120 exposure may also 
upregulate R5 membrane expression. Mouse hippocampal neurons were treated with 250 pM of R5 and 
X4-tropic gp120 for 16 h before being fixed and immunostained for R5 or X4. However, no increase in 
expression of either receptor was detected (data not shown).
2.4.3. Inhibition of X4 with receptor-specific antagonist AMD3100 blocks rod formation
Whereas gp120 binding to R5 and X4 co-receptors is required for facilitating viral envelope 
fusion with the host membrane, interactions with other neuronal receptors, including N-methyl-D- 
aspartate receptors (NMDAR) and nicotinic acetylcholine receptors (nAChR) have been reported (Bracci 
et al., 1992; Xu et al., 2011; Ballester et al., 2012; Capó-Velez et al., 2018). Having demonstrated that 
gp120 co-receptors are present in the membrane of rodent hippocampal neurons, we sought to confirm 
that it is the interaction of gp120 with these specific chemokine receptors that triggers rod formation. To 
41
this end, we exposed 6 DIV cultured mouse hippocampal neurons to 250 pM R5, X4, or dual tropic gp120 
in the presence of 100 nM maraviroc and 50 nM AMD3100, receptor specific inhibitors for R5 and X4, 
respectively. In neurons exposed to either R5-tropic gp120, we did not measure a significant decrease in 
rod index with the inhibition of either receptor although there was a measurable decrease in rod index in 
cultures exposed to maraviroc (Figure 2B). Rod index was restored to control levels in neurons exposed 
to X4-tropic gp120 in the presence of AMD3100, suggesting that gp120-mediated signaling through X4 
may be a more potent activator of rod induction (Figure 2B). Neither maraviroc nor AMD3100 
significantly affected rod induction in cultures exposed to the opposite receptor-binding gp120 strain. For 
dual-tropic gp120, only AMD3100 significantly reduced the number of rods, confirming the observation 
that rod induction is more sensitive to gp120 signaling through X4 (Figure 2B). Indeed, for both dual- and 
X4-tropic gp120, blocking X4 with AMD3100 returned rods to basal levels supporting the hypothesis that 
rod induction by gp120 is occurring through a CXCR4-mediated signal transduction pathway.
2.4.4. Gp120 mediates rod formation through a cellular prion protein PrPC- dependent pathway that 
requires the NOX activation
Rod induction by Aβd/t and proinflammatory cytokines occurs through a PrPc-dependent signaling 
pathway linking these ligands to the activation of NOX (Walsh et al., 2014). We hypothesized that gp120- 
mediated rod induction must also require membrane expression of PrPC and active NOX. To test this 
hypothesis, we exposed hippocampal neurons cultured from PrPC null mice to all three gp120 tropic 
strains. Unsurprisingly, none of the tested strains of gp120 induced rod formation (Figure 3A). To verify 
the requirement of PrPC expression for gp120 mediated rod formation, we infected PrPC-null hippocampal 
neurons with adenovirus expressing EGFP-PrPC driven by a cytomegalovirus (CMV) promotor that has 
previously been demonstrated to drive the expression of functional PrPC at the membrane surface (Haigh 
et al., 2005). In neurons re-expressing PrPC, 18 h treatment with 250 pM of each tropic strain of gp120 
induced a significant increase in rod formation over control (p£0.005) (Figure 3B). Having confirmed the 
essential role of PrPC in mediating gp120 induced rod formation, we next sought to confirm the 
requirement for active NOX.
Active NOX2, a superoxide (O2-) generating multi-subunit enzyme, is comprised of two 
membrane subunits (gp91pHoX, p22phox) and three cytosolic components (p47phox, p67phox, and p40phox) 
in addition to the ancillary small GTPase Rac1. To test the requirement for NOX activity in rod induction 
by gp120, we employed a combination of pharmacological, molecular, and genetic approaches to block 
NOX activity. First, we used the NOX inhibitor TG6-227 (kindly provide by Dr. David Lambeth, Emory 
University GA) and exposed cells to dual-tropic gp120. We found rod formation was significantly 
reduced in TG6-227-treated neurons when compared to neurons exposed to gp120 in the absence of 
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inhibitor (p=0.002)(Figure 4A). Next, we infected mouse hippocampal neurons with adenovirus 
expressing the dominant-negative mutant of the NOX small membrane subunit p22phox (DNp22phox) at 
30 and 100 MOI (multiplicity of infection), thus inhibiting NOX activation. DNp22PHoX-expressing 
hippocampal neurons showed no increase in rod induction when exposed to 500 pM dual-tropic gp120 at 
either MOI tested (Figure 4B). In contrast, both control neurons and those infected with adenovirus 
expressing the lacZ reporter (control infected) responded to dual-tropic gp120 with a nearly 4-fold 
increase in rods (Figure 4B). Lastly, we showed that the absence of the cytosolic membrane subunit 
p47phox (p47PH0X-null mouse line) prevented rod formation induced by each gp120 strain (Figure 4C). 
Together these results demonstrate the inhibition of NOX activity is sufficient to block gp120-induced 
rod formation.
2.5. Discussion
Here we describe for the first time HIV gp120-mediated induction of cofilin-actin rods as a novel 
mechanism underlying synaptic dysfunction in HAND. Mouse hippocampal neurons were found to 
significantly increase both the percentage of neurons with rods as well as the number of rods in neurites 
following gp120 exposure. Rod induction requires gp120 interaction with R5 or X4 chemokine receptor 
and occurring through a pathway dependent on both PrPc and NOX.
Cofilin:actin rod induction is a well-documented cellular response to neurodegenerative stimuli 
including mitochondrial dysfunction, ischemia/reperfusion, NMDA receptor mediated excitotoxicity, and 
the PrPc/NOX-dependent stimuli Aβd∕t, pro-inflammatory cytokines, and now, gp120 (Chen et al., 2012; 
Walsh et al., 2014; Won et al., 2018).
Common to all rod inducers is the increased production of ROS in neurons exposed to these 
stimuli. We provide evidence that for gp120, activation of NOX which produces ROS is causal to rod 
formation supported by the absence of rod induction in cultures exposed to gp120 after preventing NOX2 
activity through pharmacological inhibition, the introduction of dominant-negative mutation in the 
p22phox membrane subunit, or the gene-knockout of cytosolic subunit p47phox. Furthermore, we 
demonstrate that PrPc-null mouse hippocampal neurons do not generate rods in response to gp120 
exposure. However, re-expressing PrPc successfully recovered the potency of gp120 to induce rods in 
these cells. Notably, the neurotoxic Aβd∕t also requires NOX and is further dependent on the expression of 
PrPc for induction of rods (Walsh et al., 2014).Taken together, these results provide evidence that rod 
induction via the PrPc/NOX-dependent pathway may be a common mechanism underlying synaptic loss 
observed for a number of neurodegenerative diseases, including Alzheimer's disease and HAND.
HIV infection in the CNS appears restricted to microglia and macrophages while causing injury 
and apoptotic death in neurons (Jordan et al., 1991; Bell, 1998; Gerngross and Fischer, 2015). As such, 
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there has been some debate as to the mechanisms of neurotoxicity— whether neuronal injury observed in 
HAND is the result of indirect effects mediated by the release of neurotoxic, proinflammatory host factors 
from infected or activated glial cells, or rather the result of a direct neurotoxic effect of soluble HIV 
proteins shed from infected host cells and virus. Gp120 is a potent HIV neurotoxin implicated in 
promoting neurodegeneration through a combination of both indirect and direct actions (Kaul and Lipton, 
1999; Wallace, 2006; Mocchetti et al., 2012; Smith et al., 2018). Gp120 has been shown to trigger the 
release of pro-inflammatory and pro-apoptotic cytokines, including TNF □, from infected macrophages 
and activated microglia, in an indirect mechanism of neuroinflammation (Guo et al., 2013; Festa et al., 
2015; Planes et al., 2018). Mechanisms of direct neurotoxicity are mediated by gp120 interactions with 
host receptors at the neuronal membrane. In addition to its R5 and X4 co-receptors, gp120 has also been 
demonstrated to directly interact with neuronal NMDAR and □7-nAChR leading to increased 
intracellular calcium and induction of apoptosis (Bracci et al., 1992; Corasaniti et al., 2017).
Dissociated mouse hippocampal cultures are virtually devoid of microglia cells (Supplemental 
Figure S2) yet contain a population of astrocytes, which do not secrete detectable levels of 
proinflammatory cytokines as shown (Walsh et al., 2014). This allowed us to determine if gp120 
interaction with chemokine co-receptors on the neuronal membrane activated the PrPc/NOX-mediated 
pathway of rod induction via a direct mechanism. Our results support gp120-mediated rod formation 
results from the direct interaction of gp120 and neuronal R5 or X4 receptors. Interestingly, while 
signaling through either R5 or X4 induced a significant increase in rod index, there appear to be 
differences in the strength of induction associated with individual receptors. Blocking either receptor from 
interacting with gp120 led to a reduction in rods induced by receptor-tropic gp120 strains tested; however, 
only AMD3100 inhibition of the X4 receptor significantly reduced rod induction to levels of untreated 
controls for both dual-tropic and X4-tropic strains of gp120. We did not observe a significant decline in 
rod production for cultures treated with maraviroc to block rod formation by dual-tropic or R5-tropic 
gp120. Indeed, it appears that blocking gp120∕R5-mediated rod induction achieves only a partial block of 
rod induction. Though maraviroc treatment did achieve a reduction in rods, widespread cytotoxicity was 
observed in neuronal cultures treated with an initial concentration of 20 mM for inhibition of R5. To 
avoid neuron loss, the concentration of maraviroc was reduced to 100 nM, a concentration used widely in 
the literature. At 100 nM, we observed a small reduction in gp120 induced rod formation without 
apparent cytotoxicity. However, it is possible that at this lower maraviroc concentration we are not fully 
inhibiting R5 receptors, the remainder of which can then activate rod induction in response to gp120 
binding. Notably, inhibiting R5 with maraviroc had no effect on rod formation activated via X4-mediated 
signaling. Likewise, X4 inhibition with AMD3100 had no effect on R5-mediated rod induction. Thus, rod 
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induction activated by different tropic-strains of gp120 is indeed receptor specific and independently 
activated by each receptor.
HAND in the post-cART era is no longer characterized by neuronal loss and brain atrophy; rather, 
neuronal synaptopathy has emerged as a hallmark of HIV-mediated neurotoxicity (Wenzel et al., 2019a). 
There is increasing evidence to support that impairments in neuronal cytoskeleton structure and function 
underlie synaptopathy observed in HAND and that it is the action of neurotoxic HIV proteins driving 
these impairments (Avdoshina et al., 2017; Avdoshina et al., 2019; Wenzel et al., 2019b). Though gp120 
has been demonstrated to play a role in synaptic dysfunction and dendritic simplification thought to 
underlie cognitive impairments observed in HAND, the mechanisms underlying gp120-mediated synaptic 
damage are not well understood (Masliah et al., 1997; Iskander et al., 2004). The activation of a 
PrPc/NOX-mediated pathway of rod induction is one potential mechanism for gp120-induced synaptic 
dysfunction involving the perturbation of neuronal cytoskeleton dynamics.
Persistent rods have been observed during the progression of Alzheimer's and other 
neurodegenerative diseases (Minamide et al., 2000b; Chen et al., 2012; Rahman et al., 2014). In these 
pathologies, rods have been demonstrated to induce synapse loss by the interruption of vesicular transport 
due to occluded neurites (Maloney et al., 2005; Cichon et al., 2012). Rods have further been linked to 
synaptic dysfunction via sequestration of cofilin from dendritic spines where it has a role in post-synaptic 
plasticity (Gu et al., 2010; Rust, 2015)Thus, synaptopathy observed in HAND may arise from 
cytoskeletal aberrations induced by gp120 signaling through R5 and X4 in the form of cofilin-actin rods. 
Interestingly, a recent study reported dendritic simplification and cognitive flexibility in a transgenic rat 
model of HIV-1 infection can be rescued with the intracebroventricular administration of chemokine 
CXCL12, the endogenous ligand for the X4 receptor (Festa et al., 2020). Presumably, CXCL12 
outcompetes gp120 to bind CXCR4, not only preventing gp120-associated synaptic toxicity, but also 
appearing to activate a pathway that seemingly reverses dendritic damage observed in HAND. That two 
different ligands signaling through X4 to generate opposite outcomes is not unheard of. Indeed, CXCL12 
and gp120 signaling through X4 has previously been reported to differentially activate the spontaneous 
activity of Cajal-Retzius cells to opposite outcomes (Marchionni et al., 2012). In this study, the authors 
propose the ability of these CXCL12 and gp120 to modulate excitability of these cells in opposite 
directions results from the activation of distinct pools of intracellular calcium by each ligand. In the case 
of gp120/CXCL12 signaling and dendritic spine morphology, it may be that gp120 and CXCL12 
signaling through X4 similarly activate different intracellular targets to modulate cytoskeletal effects.
These results provide evidence to support potential therapeutics that targeting rod formation could 
ameliorate not only HAND but also pathologic rod formation in response to several neurodegenerative 
stimuli, including Aβ oligomers and proinflammatory cytokines. Our results demonstrate gp120 co­
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receptor antagonists— specifically AMD3100 inhibition of X4, would be a potential mechanism to block 
rod formation. Further, Festa et al. (2020) demonstrated CXCL12-mediated rescue of dendritic spines 
suggesting gp120 co-receptor agonists should also be considered for their potential to activate protective 
pathways against gp120-mediated toxicity. The importance of membrane architecture as a regulator of 
protein function in the gp120-mediated pathway to rod formation cannot be understated. Membrane lipid 
raft domains serve not only as critical sites of interaction for chemokine receptors, but are also essential 
for the appropriate receptor conformation to support co-receptor function (Nguyen and Taub, 2002; Jana 
and Pahan, 2004). Recent studies have attributed a ‘chaperone-like' allosteric function for cholesterol in 
stabilizing structural elements of integral membrane proteins through a cholesterol recognition/interaction 
amino acid consensus sequence, with demonstrable alterations of protein function by modulating 
cholesterol interactions (Fantini, 2003; Fantini and Barrantes, 2013). Notably, putative cholesterol 
binding sites have been identified in the structure of both R5 and X4, supporting the necessity of lipid raft 
localization for proper receptor function (Zhukovsky et al., 2013; Legler et al., 2017). Further, both PrPC 
and NOX2 are localized to raft domains where raft composition similarly affects conformational stability 
and enzyme activity (Taylor and Hooper, 2006; Jin et al., 2011; Botto et al., 2014). Lipid rafts have been 
implicated in the pathology of several neurodegenerative disorders, including Parkinson's, Huntington's, 
and Alzheimer's disease where altered raft composition appears to underlie changes in signal transduction 
contributing to pathogenesis (Sonnino et al., 2014; Grassi et al., 2019). As gp120-induced rod formation 
requires signaling not only through lipid-raft localized receptors, but also the involvement of proteins tied 
to raft domains, membrane architecture becomes an important potential target for drug discovery and 
therapeutics directed against HAND.
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2.6. Figures and Tables
Figure 2.1. Dual-, R5-, and X4- tropic gp120 induce dose- and time-dependent rod formation in E16 
mouse hippocampal neurons. A) Cells were grown on coverslips and treated with 250 pM dual-tropic 
gp120MN (ii), R5-tropic gp120CM (iii), X4-tropic gp120IIIB (iv) or untreated (i) for 16 hours then 
immunostained for cofilin and imaged. Each of the gp120 strains tested induced robust rod formation 
(arrow indicates rod). B) Hippocampal neurons were treated with increasing concentrations of dual-, R5-, 
and X4- tropic strains of gp120 and processed as described above. Rods were found to form in a dose­
dependent manner (* p<.01, ** p=.03, *** p=.0002, **** p<.0001). C) Percent of neurons expressing 
rods was quantified at 4, 6, 8, 12, 16, and 24 hours post exposure to 500 pM dual-tropic gp120. Gp120 
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induced rods significant above control from 6 hours onward (significance above dotted line p£.01). D) A 
wash-out of gp120 after 24 h significantly reduced rod formation (p<.0001). No additive effect was 
observed upon incubation with both gp120 and TNF-α or amyloid-β. w-o = washout, GP+TNF = 500 pM 
gp120 & 50 ng/mL TNF-α, GP+Aβd∕t= 500 pM gp120 & 200 pM Aβd∕t
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Figure 2.2. The CXCR4 receptor inhibitor AMD3100, but not CCR5 inhibitor maraviroc, blocks rod 
induction by CXCR4 binding gp120 strains. A) E16 mouse hippocampal neurons grown on coverslips 
were fixed on DIV7 and immunostained for CCR5 (i) and CXCR4 (ii). Both receptors were found to be 
widely expressed in these neurons. B) Neurons were pre-treated with 100 nM maraviroc or 50 nM 
AMD3100 for 1h prior to gp120 exposure and maintained throughout the 16-hour treatment. CXCR4 
inhibitor blocked rod induction by X4-binding strains of gp120 returning the rod index to control levels 
(p<.01). CCR5 inhibitor maraviroc induced a nominal reduction in rod index of cells treated with R5- 
binding gp120 strains (p=.06).
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Figure 2.3. Gp120 mediated rod inductions requires the expression of cellular prion protein (PrPC). E16 
mouse hippocampal neurons cultured from a PrPC-null mouse were exposed to each of the gp120 strains 
(250 pM, 16 h) and rod index calculated. None of the gp120 strains tested induced rod formation in PrPc- 
null neurons above control. PrPC-null neurons were then infected with adenovirus expressing EGFP-PrPC 
to drive re-expression of the protein. Infected cells were then exposed to 250 pM gp120 as described 
above and rod index calculated. In infected cells re-expressing PrPC, all strains of gp120 tested induced 
rod formation significant above control (** p=.0053, *** p=.0003, **** p<.0001).
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Figure 2.4. Gp120 induced rod formation occurs via a NOX2 mediated pathway. NOX2 activity was 
inhibited using pharmacologic, molecular and genetic approaches. A) The NOX2 specific inhibitor TG6- 
277 blocks dual-tropic gp120 mediated rod formation. B) Adenoviral infection of mouse hippocampal 
neurons with virus expressing dominant-negative mutant of NOX2 membrane subunit p22PHOX blocked 
dual-tropic gp120 induced rod formation at both MOIs tested. C) Hippocampal neurons from a cytosolic 
subunit p47PHOX knock-out mouse were exposed to gp120 and evaluated for rod formation. No strains of 
gp120 tested induced rod formation above control levels in p47PHOX-null neurons.
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Supplemental Figure 2.1. R5- and X4-tropic gp120 induce time-dependent rod formation in E18 rat 
cortical neurons. Cells were grown on coverslips and treated with 250 pM R5-tropic gp120CM and X4- 
tropic gp120IIIB for indicated time then fixed, immunostained for cofilin, and imaged. While each of the 
gp120 strains tested induced rod formation, X4-tropic gp120 induced a more potent response, reaching 
significance above control at 1 hour post-exposure (* p<.01).
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Supplemental Figure 2.2. Dissociated mouse hippocampal neurons are virtually devoid of microglia.
E16.5 mouse hippocampal neurons were grown on coverslips, fixed on DIV7 and stained for DAPI which 
will stain nuclei of all cell types and Iba-1, a specific marker of microglia cells. An overlay of DAPI and 
Iba-1 reveals very few Iba-1 positive microglia in the culture.
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Chapter 3. Lipid Raft Coalescence Links Gp-120 Induced Oxidative Stress to Neurodegeneration
3.1. Abstract
HIV-associated neurocognitive disorders (HAND) affect nearly 50% of infected individuals. 
Current in vitro models for investigating the cellular and molecular mechanisms underlying HAND rely 
almost exclusively on the use of murine primary neurons and human neuronal cell lines. Despite the 
usefulness of these models, cells sourced from non-human hosts limit the applicability of results obtained, 
while human neuronal cell lines often exhibit neuropotential but not neuronal morphology. Notably, the 
SH-SY5Y human neuroblastoma cell line can be terminally differentiated into a phenotype expressing 
markers of mature neurons, as well as a morphology characteristic of mature neurons We sought to 
establish a human model of HIV envelope protein gp120-induced neurotoxicity by using human SH- 
SY5Y neuroblastoma cells to investigate the ability of gp120 to activate a pathway demonstrated to lead 
to the formation of pathologic cofilin-actin rods in primary murine neurons. To this end, we assessed 
cellular response to gp120 exposure by measuring lipid raft coalescence and the generation of reactive 
oxygen species, and further sought to assess the applicability of terminally differentiated SH-SY5Y cells 
as a reproducible neuronal model of human origin for the investigation of gp120 induced rod formation. 
We demonstrate here that gp120 induced lipid-raft coalescence in SH-SY5Y cells occurs in a dose­
dependent manner. Moreover, gp120 exposure activated NOX2 and a concomitant generation of 
superoxide. While these are critical steps in the activation of rod induction in murine neurons, we did not 
observe any effect of gp120 on the production of cofilin-actin rods in differentiated SH-SY5Y cells.
3.2. Introduction
Nearly 50% of individuals with long-term HIV infection are affected by the onset of progressive 
neurological and cognitive complications referred to as HIV-associated neurocognitive disorders (HAND). 
While improvements in HIV treatments have contributed to a decline in the incidence of the severe 
dementias previously associated with HAND, the prevalence of milder forms of HAND remain stable and 
continue to have profound impacts on the quality of life for infected individuals. Indeed, the prevalence of 
HAND is expected to rise with the ageing population of HIV infected individuals— in the United States 
alone, of the 1.2 million people living with HIV infection, an estimated 50% are older than 50 years of 
age (Wing, 2016; Negredo et al., 2017). It has become apparent that complications from HIV infection
Authorship for this chapter is as follows: Lisa Smith, Daniel Dykes, and Thomas Kuhn. In preparation for 
submission to Neurotoxicology.
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overlap with other age-associated neurodegenerative diseases, including Alzheimer's disease, with 
evidence increasingly indicating that HIV-1 infection contributes to age-associated cognitive decline 
(Green et al., 2005; Achim et al., 2009; Cohen et al., 2015; McLaurin et al., 2019). As such, 
complications of long-term HIV infection, including HAND, remain a continuing public health challenge 
in the post-cART era (Alford and Vera, 2018).
HIV infiltrates the CNS early during primary infection where it establishes persistent infection in 
resident macrophages and glial cells that in turn release inflammatory cytokines and neurotoxic viral 
proteins that can perturb neuronal function (Gras and Kaul, 2010). The viral envelope protein gp120 has 
been identified as a potent neurotoxin affecting neurodegeneration not only via indirect mechanisms, but 
also through the direct interaction of the protein with host-cell chemokine co-receptors CCR5 and 
CXCR4 where preferential binding of gp120 to CCR5 or CXCR4 determines viral tropism (Smith et al., 
2018). The interaction of gp120 with co-receptors has been demonstrated to directly affect 
neurodegeneration through multiple pathways, including activation of neuronal apoptosis via interaction 
with N-methyl-d-aspartate receptors (NMDAR), the induction of neuronal reactive oxygen species (ROS) 
and nitrosative stress, and axonal degeneration mediated by co-receptor activation. (Pattarini et al., 1998; 
Kaul et al., 2001; Jana and Pahan, 2004; Melli et al., 2006; Pandhare et al., 2015). While synaptic 
disruption is frequently observed in conjunction with apoptosis, in the absence of neuronal loss 
synaptodendritic injury is likely to be underlying the cognitive decline seen in HAND (Ru and Tang, 
2017; Guha et al., 2018; Mackiewicz et al., 2019).
Notably, we have identified a pathway leading to synaptic and dendritic dysfunction mediated by 
gp120 interaction with CCR5 and CXCR4 co-receptors in rodent hippocampal and cortical neurons 
(Chapter 2). This pathway appears common to Alzheimer's associated amyloid-β (Aβ) oligomers and 
proinflammatory cytokines and is composed of the cellular prion protein (PrPC) and NADPH oxidase-2 
(NOX2) embedded in coalesced lipid raft macrodomains (Walsh et al., 2014). NOX2 is comprised of 6 
subunits— 2 integral membrane proteins, 3 cytosolic regulatory proteins, and a guanine nucleotide 
binding protein— that interact to form the active enzyme complex (Panday et al., 2015). Upon activation, 
cytosolic regulatory proteins, including p67PHOX, translocate to the plasma membrane and complex 
integral membrane proteins to assembly the active enzyme. Subsequent ROS generation is causative to 
the formation and accumulation of rod-like cofilin-actin inclusions (rods) in neuronal processes, which 
have been linked to synaptic dysfunction via sequestration of cofilin as well as disruption of vesicular 
transport resulting from the occlusion of neurites containing rods (Bamburg et al., 2010).
Murine cells are commonly used for the investigation of both the cellular and molecular 
mechanisms underlying both HAND and pathologic rod formation in response to various stimuli. These 
cells are a useful alternative to primary human neurons owing to the expense and ethical issues involved 
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in obtaining primary neuronal cells of human origin. However, these non-human origins may affect 
experimental outcomes and limit the applicability of results, particularly for viruses specific to human 
hosts, like HIV. Indeed, we have identified differences in chemokine receptor expression between rodent 
and human neurons that have the potential to confound results obtained from experiments requiring direct 
gp120-receptor interactions. To overcome the limitations associated with the use of animal cells in the 
investigation of a human disease, we proposed to evaluate the ability of gp120 to induce cofilin-actin rods 
in neurons of human origin.
The human neuroblastoma cell line SH-SY5Y has been widely used to model human 
neurodegenerative disease, including HAND. While in their undifferentiated form SH-SY5Y cells rapidly 
proliferate and exhibit short, spiky processes, these cells can be differentiated to exhibit long, branched 
processes more typical of primary neurons (Shipley et al., 2016). This is of particular importance when 
investigating gp120 mediated rod formation, as pathologic rod formation occurs in neuritic processes, and 
thus any cellular model for rod formation requires the long processes seen in primary neurons. Here, we 
present data to show that consistent with data obtained in murine primary neurons, undifferentiated SH- 
SY5Y cells responded to gp120 exposure with a marked coalescence of lipid raft into macrodomains and 
the rapid generation of NOX2-mediated ROS production. Further, we evaluate differentiated SH-SY5Y 
cells as a model for gp120 induced rod formation in cells of human neurons.
3.3. Materials and Methods
3.3.1. Chemicals, Biological, Antibodies
R5-tropic gp120CM and X4-tropic gp120LAV were purchased from ProSpecBio (Ness-Ziona, Israel) 
and dual-tropic gp120MN purchased from ImmunoDX (Woburn, MA). VybrantTM AlexaFluorTM 594 Lipid 
Raft labeling kit and Cholera toxin subunit B (recombinant) Alexa FluorTM 488 conjugate were purchased 
from ThermoFisher Scientific (Waltham, MA). Primary anti-p67 phox antibody was purchased from 
Abcam (Cambridge, MA). Recombinant human TNFa was received from ProSpecBio (Ness-Ziona, 
Israel). 2',7dihydrodicholorfluorecein diacetate (H2DCFDA), Dihydroethidium (DHE), and PrestoBlue 
Cell Viability reagent were purchased from ThermoFisher Scientific (Waltham, MA).
3.3.2. Cell culture
SH-SY5Y cells were obtained from American Type Culture Collection (ATCC CRL-226) and 
maintained in the undifferentiated phenotype using EMEM with 2mM L-glutamine (ThermoFisher) 
supplemented with 10% Hyclone fetal bovine serum (VWR) and 100 U/mL penicillin/streptomycin 
(VWR) at 37oC as a growth medium. Differentiating SH-SY5Y Cells. To differentiate SH-SY5Y cells into 
a more neuronal phenotype, a previously described protocol was employed (Shipley et al., 2016). Briefly, 
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SH-SY5Y cells were grown on extracellular matrix (MaxGel ECM, Sigma, St. Louis, MO)- coated 12 
mm glass coverslips subjected to three different differentiation mediums containing sequentially less 
serum and including 10mM retinoic acid. The protocol was modified to reduce incubation duration in 
each differentiation medium, reducing time periods from 6 days to 4 days and decreasing overall time to 
differentiation from 18 days to 12 days (see figure 3.3. for greater detail).
3.3.3. Lipid raft assays
For imaging lipid rafts, SH-SY5Y cells were grown on rat collagen coated coverslips until 80-90% 
confluent. Cells were serum starved for 24 hours prior to treatment with gp120. Cells were exposed to 
gp120 by complete media exchange and gp120 was maintained in culture medium for the duration of 
experiments. Lipid rafts were visualized using Vybrant AlexaFluor 594 Lipid Raft labeling kit according 
to manufacturer's directions, stained for DAPI, and fixed in 4% paraformaldehyde. Images were acquired 
using an Olympus Inverted Research Microscope (motorized Model 1X81) using SlideBook Software and 
analyzed using MetaMorph software. To quantify raft coalescence, images were converted to grayscale (8 
bit), binarized, and overlaid with the original image to isolate lipid raft domains in regions of interest. The 
mean integrated intensity of all rafts per condition was calculated and used to determine significance. 
Lipid raft coalescence was also quantified using a plate reader approach. SH-SY5Y cells were grown in 
black 96-well plates with clear bottoms and exposed to 500 pM of each gp120 strain for 2.5, 5, and 24 
hours. Lipid rafts were labelled with Alexa488 conjugated cholera toxin subunit B and fluorescence 
detected using a multiplate reader (Beckman Coulter Multimode DTX 880 microplate reader).
3.3.4. ROS assays
Formation of intracellular ROS were quantified using the oxidation sensitive fluorescence 
indicators H2DCF-DA and DHE. H2DCF-DA detects the general presence of ROS, while DHE provides a 
superoxide (O2-) specific measure of ROS. With regard to H2DCF-DA, SH-SY5Y cells grown in 96 well 
plates were loaded with 1 μM H2DCF-DA in serum-free DMEM (1 h, 37°C) followed by exposure to 250 
pM and 500 pM of either R5-tropic or X4-tropic gp120. DCF fluorescence was measured starting at 5 
min post addition and every 15 min thereafter, for a total of 155 minutes, by plate reader (Beckman 
Coulter Multimode DTX 880 microplate reader). Total DCF fluorescence (ex/em 495/525) from each 
well was adjusted to the number of viable cells using PrestoBlue (cell viability reagent, absorbance 
measured at 570 nm) and normalized to control. With regard to DHE, SH-SY5Y cells were loaded with 
5 □M H2Et (100 μl total volume/well, 30 min, 37°C) in the dark due to the light sensitivity of DHE. Cells 
were rinsed once with serum free EMEM prior to exposure to 250, 500, and 1000 pM R5 or X4-tropic 
g120 for 2.5 h. Cells were rinsed 2X with warm HBSS and medium replaced with 100 μl Leibovitz 
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medium without phenol red. Excitation/emission was measured at 590/620 for the detection of O2- 
specific oxidation by plate reader (described above).
3.3.5. Biotinylation of membrane proteins and plasma membrane association of p67PHOX
SH-SY5Y cells were grown to confluence in 6-well plates and treated with 250 pM dual-tropic 
gp120 for 10 or 30 min. Following gp120 exposures, plasma membrane proteins were biotinylated by the 
method described (Li and Shah, 2002). Briefly, cultures were rinsed and incubated on ice with 0.5mg/mL 
membrane impermeable EZ-LinkTM-NHS-SS-Biotin (ThermoFisher Scientific) in a HEPES buffer . Next, 
cells were scraped into solution, centrifuged (200xgmax, 2 min), and gently lysed (TBS w/ 0.5% TritonX) 
by sonicatation (on ice). Cells lysates were cleared by centrifugation (24,000xgmax, 5min, 4oC) and 
supernatants transferred to fresh microcentrifuge tubes. Each lysate (500 μl) was incubated with 20 μl 
streptavidin agarose beads (ThermoFisher Scientific, Waltham, MA) for 1 h at RT while rocking. Beads 
were pelleted (5,000gmax, 5min, 4oC) and washed twice with TBST (500 μl /wash). Bound protein was 
released from beads by resuspending in 400uL TBST with 50mM DTT (freshly made) and incubating for 
1h at RT while rocking. After incubation, beads were spun at 5,000gmax for 5 min (4oC) and supernatants 
recovered and used to coat a 96-well ELISA plate (80uL protein suspension/well) overnight at 4oC. 
before incubation with primary antibody against p67phox (1 h, RT) then followed by HRP-conjugated 
secondary antibody (1:100, 1 h RT) . Plate was washed 3X before incubating with 1-StepTM Ultra TMB- 
ELISA Substrate Solution (ThermoFisher Scientific, Waltham, MA) for 15 minutes (or until blue 
coloration is visible) and reaction stopped with 1M H2SO4. Absorbance was measured at 450nm using a 
Beckman Coulter Multimode DTX 880 microplate reader. Data was adjusted to protein expression of 
NCAM used as an internal control.
3.3.6. Immunostaining for cofilin-actin rods
SH-SY5Y cells were grown on 12 mm round glass coverslips inserted into a 24 well plates and 
differentiated to D-8 and D-12. Cultures were treated with 250 pM dual-tropic gp120 ( 18 h) prior to 
fixation in 4%formaldahyde/0.1%glutaraldahyde for 20 minutes and permeabilization with ice-cold 
methanol for 3 minutes. Coverslips were rinsed with PBS (3X) and blocked in 1%BSA and goat serum in 
TBS (1 h). Coverslips were then incubated with a rabbit anti-cofilin antibody (1:100 concentration, 
AbCam, Cambridge, MA) overnight at 4oC. Coverslips were rinsed 3 x with PBS and incubated with 
Alexa488-conjugated anti-rabbit secondary antibody (1:500, 1 h, RT)), washed and mounted on glass 
slides using pro-long gold antifade cell mounting media with DAPI (ThermoFisher). Images were 




Quantification of all experiments were performed with at least triplicate samples for each 
condition and repeated in at least three independent experiments with the exception of biotinylation and 
membrane localization of p67PHOX, which was repeated in two independent experiments. Lipid raft 
image data were assessed for Gaussian distribution and raft coalescence analyzed by Kruskal Wallis test 
with Dunn's post-hoc analysis for multiple comparisons (non-parametric data) using GraphPad Prism 
software. 96-well plate-based raft coalescence, DCFDA and DHE ROS production, and rod formation 
were analyzed by one-way ANOVA followed by Dunnett's post-hoc analysis with GraphPad Prism (San 
Diego, CA) software. An alpha value of 0.05 for used for all analyses.
3.4. Results
3.4.1. Gp120 induces dose-dependent lipid raft coalescence in SH-SY5Y neuroblastoma cells.
Gp120 interaction with host cell receptors is restricted to membrane lipid raft domains with rafts 
serving to compartmentalize cellular processes and facilitate protein-lipid / protein-protein interactions 
and signal transduction events. Raft coalescence has been proposed as a mechanism for clustering the 
components of receptor-activated signaling cascades, and gp120 has previously been demonstrated to 
induce raft coalescence in human hippocampal neurons (Jana and Pahan, 2004). Notably, PrPC is 
localized to lipid rafts, where the early association of the protein with the cholesterol-enriched 
environment is thought to facilitate its proper folding (Sarnataro et al., 2004). Further, activation of 
NOX2— and in particular the assembly of its cytosolic subunits p40PHOX, p47PHOX, and p67PHOX, together 
with Rac1 — has been shown in most cell types to be dependent on the lipid raft environment (Haslund- 
Vinding et al., 2017). Indeed, both HIV co-receptors CCR5 and CXCR4 have been demonstrated to 
localize to lipid rafts in response to gp120 exposure, where interaction with membrane cholesterol 
supports the proper conformation and activity of the receptors (Nguyen and Taub, 2002; Yi et al., 2006; 
Kamiyama et al., 2009). As both PrPC expression and NOX2 activity are required for rod induction by 
gp120 in rodent neurons, we tested the hypothesis that gp120 binding to co-receptors CCR5 and CXCR4 
would lead to an increased size and stability of raft domains. SH-SY5Y cells grown on glass coverslips 
were exposed to increasing doses of dual-tropic gp120MN for 2.5 hours and lipid rafts visualized with 
Alexa564-labeled Cholera toxin subunit B (CTXB), which binds the lipid-raft anchored ganglioside 
GM1. We found that raft coalescence in SH-SY5Y cells significantly increased in a dose-dependent 
manner when exposed to dual tropic gp120MN (p<.0002) (Figure 1A). The pro-inflammatory cytokine 
TNFα which has previously been demonstrated to induce lipid raft coalescence and cofilin-actin rod 
formation (Gustafson et al., 2012; Walsh et al., 2014), similarly induced the coalescence of lipid rafts in 
SH-SY5Y cells (p<.0001). Having demonstrated that gp120 is capable of inducing lipid raft coalescence 
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in these cells, we next explored the effect of each gp120 strain on lipid raft coalescence as a function of 
time. SH-SY5Y cells grown in 96-well plates were exposed to 500 pM dual-tropic gp120MN, R5-tropic 
gp120CM, and the X4-tropic gp120LAV for a duration of 2.5 h, 5h, and 24 h before fluorescently labeling 
lipid rafts with Alexa488-conjugated CTXB and quantifying lipid raft coalescence. We found that while 
all strains of gp120 tested induced significant lipid raft coalescence by 5 hours post-exposure (p<.0001), 
any measurable differences in raft size between exposed and unexposed cells were lost at 24 hours post­
exposure (data not shown), suggesting that gp120 induced raft coalescence and any associated activation 
of signaling is not sustained long term (Figure 1B).
3.4.2. Gp120 activates NOX2 to generate ROS
ROS plays a critical role in the pathway to formation of cofilin-actin rods, where oxidation 
induced changes in cofilin lead to the formation of disulfide-linked cofilin dimers necessary for bundling 
cofilin-actin filaments into rods (Bamburg et al., 2010). To confirm that SH-SY5Y cells generate ROS in 
response to gp120 stimulation as observed in murine neurons, we exposed cells in 96-well plates to two 
concentrations of gp120 for both R5-tropic and X4-tropic strains and measured ROS production with the 
fluorescent ROS-indicator 2',7' -dichlorofluorescin diacetate (DCF-DA). Both strains of gp120 tested 
induced a temporary, rapid production of ROS in SH-SY5Y cells with levels returning to those of control 
by 2.5 hours post-exposure (Figure 3.2A). ROS production was greatest within five minutes of exposure 
(p≤0.05) and notably, 500 pM of X4-tropic gp120LAV induced a 14% greater rise in ROS as compared to 
500 pM R5-tropic gp120CM. This is in accordance with previous results obtained in murine primary 
neurons that suggest gp120 signaling through CXCR4 is a more potent rod inducer (manuscript in 
preparation). As NOX2 generates ROS via a redox reaction with molecular oxygen and NADPH to 
produce superoxide (O2-), we next evaluated O2- production in SH-SY5Y cells using the superoxide­
selective indicator dihydroethidium (DHE) at 2.5 h following exposure to increasing concentrations of 
dual-tropic gp120MN. Our results revealed that while gp120 induced superoxide significantly above 
control at 2.5 hours post-exposure (p≤.004)(Figure 2B). Having confirmed gp120 induced production of 
superoxide, we next sought to confirm activation of NOX2 by assessing increased plasma membrane 
association of cytosolic subunits. To this end, we exposed SH-SY5Y cells grown in 6-well plates to dual­
tropic gp120MN for 10 and 30 minutes before biotinylating plasma membrane proteins. Membrane- 
associated proteins were collected following gentle cell lysis and a streptavidin-agarose bead pull down. 
Bound material was washed, released with DTT, and used to coat a 96-well ELISA plate to detect for the 
cytosolic NOX2 subunit p67PHOX. We hypothesized gp120 activation of NOX2 would lead to a detectable 
increase of membrane-associated p67PHOX in exposed SH-SY5Y cells. We confirmed that gp120 is indeed 
activating NOX2, with a nominal increase of membrane -associated p67PHOX detectable by 10 minutes post 
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exposure (Figure 3.2C). Taken together, these results confirm that gp120 is activating NOX2-mediated 
production of superoxide in SH-SY5Y neuroblastoma cells, similar to what has been observed in the 
pathway to rod induction in primary rodent neurons.
3.4.3. Differentiated SH-SY5Y human neuroblastoma cells do not form rods in response to gp120 
exposure
To determine if gp120 signaling through CCR5 and/or CXCR4 is inducing the formation of rods 
in neurons of human origin, we sought to test the ability of all three gp120 strains in generating rods in 
SH-SY5Y cells. While undifferentiated SH-SY5Y cells exhibit truncated, immature processes (Figure 
3.3A), these cells can be differentiated to a more neuronal phenotype with long processes (Figure 3.3D) 
by a variety of methods, typically involving the gradual starvation of serum and the introduction of 
retinoic acid (RA) (Kovalevich and Langford, 2013). We chose to differentiate SH-SY5Y cells using a 
procedure adapted from Shipley et al, 2016 that involved the sequential removal of serum, continued 
presence of RA, and addition of neurotrophic factors including brain-derived neurotrophic factor (BDNF) 
from/to culture medium (Shipley et al., 2016). While the original procedure described an eighteen-day 
differentiation period with two re-plating steps, we reduced the number of days to differentiation to 
twelve, and plated cells directly onto extracellular matrix coated glass coverslips, eliminating the need for 
re-plating. We found these modifications improved the viability of our cultures without affecting 
differentiation (Figure 3.3). SH-SY5Y cells were plated on 12mm glass-coverslips coated in extracellular 
matrix and differentiated according to the modified procedure. Cells on coverslips were selected from two 
time points during differentiation— 8 days differentiated and 12 days differentiated, designated D-8 and 
D-12 (Figure 3.3C and 3.3D, respectively). For both conditions, cells were exposed to 250 pM dual-tropic, 
R5-tropic, and X4-tropic gp120 for 18 hours before being fixed and immunostained against cofilin and 
evaluated for rod formation. However, for all strains of gp120 at the concentration tested, we were unable 
to detect rod formation at either stage of differentiation evaluated (Figure 3.4).
3.5. Discussion
Here, we demonstrated gp120 signaling through both CCR5 and CXCR4 induced a dose­
dependent increase in coalesced lipid rafts and NOX2-medaited generation of superoxide in a human 
neuron-like model system. Though we confirmed similarities in the pathway to rod induction previously 
described for rodent hippocampal and cortical neurons, we were unable to recapitulate rod pathology in 
differentiated SH-SY5Y cell line.
The use of animal models to explore cellular and molecular mechanisms underlying disease has 
contributed much to the understanding of disease pathogenesis and the development of new targets for 
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therapeutic interventions. While animal cells are useful models for elements of human disease, they are 
not reflective of the entire etiology of the disease. Indeed, there is a high failure rate for the translation of 
therapeutics developed in animal models to humans (Bracken, 2009). Most current in vitro models for 
investigating rod formation rely on the use of murine primary neurons, while neuronal models used in the 
investigation of HAND often include neuron-like cells that lack the long processes more characteristics of 
mature neurons. Notably, human SH-SY5Y neuroblastoma cells can be terminally differentiated into cells 
expressing markers of mature neurons with long, branching processes, thus proving an attractive potential 
model for rod pathology in HAND. That we did not observe rod formation in differentiated SH-SY5Y 
cells is not indicative of an inability for human neurons to form rods in response to inducing stimuli— 
rods have previously been described to form in the post-mortem brains of individuals with Alzheimer's 
disease (Minamide et al., 2000). Rather, there are a number of possible factors affecting rod formation in 
SH-SY5Y cells, including the possibility that given its origins as a cancer cell line, SH-SY5Y 
neuroblastoma cells are more robust to gp120 toxicity than primary murine neurons, thus requiring a 
greater concentration of gp120 than was tested to activate the pathway to rod formation. It is also possible 
that cell density affected the ability to detect rod formation. In cultures differentiated for the entire 12-day 
protocol exposed to gp120 (Figure 3.4D), neurons were so densely interconnected that a three­
dimensional meshwork of neurite outgrowth formed, making the detection of potential rods very difficult. 
Future experiments should adjust plating density per 12mm glass coverslip from 10,000 cells/well to 
5,000 cells/well to allow for more space between cell bodies for neurite outgrowth. Finally, it is possible 
that SH-SY5Y cells, though of human origin, do not fully recapitulate the biology of disease as a 
consequence of immortality, where repeated rounds of replication introduce mutations and genetic drift 
that can potentially affect neuronal responses to various stimuli. This is supported by a study 
demonstrating SH-SY5Y cells do not endogenously express the PrPC protein. Notably, transfecting these 
SH-SY5Y to stably express PrPC rescued PrPC-mediated intracellular zinc transport (Watt et al., 2012). It 
is possible the absence of PrPC prevented gp120-mediated rod formation in differentiated SH-SY5Y cells, 
as the pathway to rod induction in murine neurons has been shown to require the expression of PrPC. Thus, 
differentiated SH-SY5Y cells as a model for gp120 induced rod pathology may still be viable with the re­
expression of PrPC , continued culture optimization, and dose-dependence studies with gp120 and other 
known inducers of rod formation.
The prevalence of neurological complications associated with prolonged HIV infection are 
expected to rise with the aging population of people living with HIV. Improving neurological outcomes in 
these individuals requires a better understanding of the molecular mechanisms underlying HIV-induced 
neurodegeneration and developing appropriate neuronal models for the investigation of the cellular 
mechanisms underlying HAND pathogenesis is a key step in improving our understanding of the disease. 
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Importantly, we demonstrate gp120 induces lipid raft coalescence in a dose-dependent manner in SH- 
SY5Y cells. Gp120 also initiated the rapid production of ROS in these cells, and levels of superoxide 
were found to be elevated above control 2.5 hours post gp120 exposure. The detection of superoxide 
suggested the involvement of NOX2 activity, which was confirmed by demonstrating gp120 triggers the 
translocation of the NOX cytosolic regulatory protein p67PHOX, to the plasma membrane. These findings 
link gp120 signaling via lipid raft associated receptors with NOX2 generated superoxide, and potentially 
to the formation of cofilin-actin rods.
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3.6. Figures and Tables
Figure 3.1. All strains of gp120 induce lipid raft coalescence in SH-SY5Y neuroblastoma cells. A. SH- 
SY5Y cells grown on glass coverslips were treated with 500 pM, 750 pM, and 1000 pM of dual-tropic 
gp120 for 2.5 hours.
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Figure 3.1 cont. Cells were also treated with 5 mM of the cholesterol chelator methyl-β-cyclodextrin, 
known to disrupt rafts, and 200 ng/mL TNFα, known to trigger lipid raft coalescence, or were left 
untreated as control. B. Representative curves of integrated intensity (FluorescenceCTXB/Area) values for 
gp120 treatments at 2.5 hours. Integrated intensity of the raft-stained SH-SY5Y cells was determined 
using MetaMorph image analysis software. Images were converted to grayscale and used to create binary 
masks to define threshold lipid raft domains in regions of interest. Overall cumulative frequency 
distribution is shown for each condition as the percentage of lipid rafts expressing integrated intensity 
values greater than X over the log of integrated intensity. Magnified portion shows the comparison of 
percent frequency of lipid rafts at X=6. Exposing SH-SY5Y cells to 750 and 1000pg of dual-tropic 
gp120MN induced a significant increase in lipid raft size (Kruskal-Wallis, p<.0002). C. SH-SY5Y neurons 
were grown in 96-well plates and exposed to 500 pM of R5-tropic gp120CM, dual-tropic gp120MN, and 
X4-tropic gp120LAV for 2.5, 5, and 24 hours. All strains tested induced significant increase in raft 
coalescence above control by 5-hours post exposure (p<.0001). This effect was lost by 24-hours post 
exposure (data not shown).
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Figure 3.2. Gp120 activates NOX2 and a concomitant formation of superoxide. A. SH-SY5Y cells 
grown in 96 well plates were exposed to 250 and 500 pM concentrations of R5-tropic or X4-tropic 
gp120 and maximum DCF fluorescence/well was measured 5 min post addition and every fifteen 
minutes thereafter, for a total of 155 minutes. ROS production was greatest immediately following 
treatment (*p≤0.05). B. SH-SY5Y cells in 96 well plates were treated with increasing concentrations 
(250, 500, 1000 pM) of dual-tropic gp120 for 2.5 h and production of superoxide detected using 
dihydroethidium. Superoxide levels were significant above control for all concentrations of gp120 
tested (**p=.004, ***p=.0005). C. Cells were grown in 6-well plates and treated with dual-tropic 
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gp120 for 10 and 30 minutes before biotinylating plasma membrane proteins. After cell lysis, 
biotinylated proteins were collected via a streptavidin-agarose bead pull down. Bound protein was 
released and used to coat a 96-well ELISA plate and was then assayed for the cytosolic NOX2 
subunit p67PHOX. A nominal increase in translocation of the cytosolic subunit p67PHOX to the plasma 
membrane at both 10 and 30 minutes post-exposure to gp120 was observed, though it did not reach 
the level of statistical significance.
72
Figure 3.3. SH-SY5Y neuroblastoma cells exhibit varying morphology during the differentiation process. 
A. Undifferentiated SH-SY5Y cells are short and stubby, often growing in small clumps and lacking 
neuritic processes. Undifferentiated cells are maintained in medium containing 2.5% serum and 10 
μM retinoic acid (RA) for four days. B. At the end of four days, cells have changed to exhibit more 
elongated cell bodies and longer processes. Cell are switched to medium containing 1% serum and 10 
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μM RA and maintained for an additional four days. C. At the end of four days, cells have developed more 
branched processes with more evidence of retracting cell bodies. At this point, cells are moved to medium 
composed of neurobasal, RA, and several neurotrophic factors while omitting all serum. D. After four 
days, cells exhibit long, exquisite neuronal branching with the small, rounded cell bodies characteristic of 
the neuronal phenotype.
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Figure 3.4. SH-SY5Y cells differentiated to Day 8 (D-8) and Day 12 (D-12) of the differentiation protocol 
do not form rods in response to gp120 exposure. Cells differentiated to D-8 (panel A) and D-12 (panel B) 
were exposed to 250pM dual-tropic gp120 for 18 hours before being fixed, immunostained against cofilin, 
and imaged at 600X magnification. D-12 cells exhibit a considerably denser network of neuritic processes 
as compared to D-8 cells.
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Chapter 4: Establishing a Protocol for the Direct Induction of Human Embryonic Stem-Cell Derived 
Glutamatergic Neurons: Towards A Model for Investigation of HAND
4.1. Abstract
Human embryonic stem cells (hESc) and inducible-pluripotent stem cells (iPSC) have emerged as 
potential solutions to the problems associated with the use of immortalized cell lines and animal models 
in the context of investigations of human disease pathologies. The capacity to generate primary neurons 
of human origin for use as cellular models would prove invaluable in better understanding the molecular 
mechanisms underlying numerous neurodegenerative diseases, from Alzheimer's disease to HIV- 
associated neurocognitive disorders. Here, we describe a method that allows for the direct induction of 
hESc to mature human neurons by the forced expression of the transcription factor neurogenin-2 (NgN2) 
with a lentiviral transduction and tetracycline-inducible expression of transduced genes driven by a tetO 
promoter. This method reliably produces human glutamatergic neurons with near 100% conversion 
efficiency and neuronal purity within 2 weeks of transduction. Neuronal cultures can be maintained long­
term (40+ days) to allow maturation before use in downstream applications.
4.2. Introduction
As of the close of 2018, the number of people living with HIV/AIDS has reached 36.9 million 
globally, with an estimated 5,000 new infections occurring daily (UNAIDS, 2019). While progress 
towards the reduction of new infections has been frustratingly slow, advances in the treatment of disease 
have contributed to a decline in mortality rates and has raised the predicted life expectancy in people with 
HIV to near normal levels (Nakagawa et al., 2012). Despite this, the complications associated with long 
term infection, including the cognitive dysfunctions reported in upwards of 50% of infected individuals, 
continue to pose a public health challenge. These progressive neurological complications are referred to 
as HIV-1-associated neurocognitive disorders (HAND) and encompass a broad spectrum of cognitive, 
motor, and behavioral abnormalities. Despite the prevalence of HIV-associated cognitive dysfunctions, 
the molecular and cellular mechanisms underlying HAND are poorly understood but are likely to consist 
of a combination of indirect mechanisms involving the release of inflammatory mediators and viral 
proteins from infected glial cells and direct effects mediated by the interaction of neurotoxic viral proteins 
with neuronal receptors.
Research into the pathophysiological mechanisms underlying HAND and other neurodegenerative
Authorship for this chapter is as follows: Lisa Smith and Thomas Kuhn.
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diseases has been hindered by the lack of relevant human neuronal models. Many of the current in vitro 
approaches to understanding the pathogenesis of HAND are performed in transformed human 
immortalized cells lines or genetically manipulated murine primary neurons (“humanized mice”), owing 
to the expense and ethical issues involved in the use of primary neurons of human origin. However, use of 
immortalized cell lines come with many caveats including cells which exhibit neuro-potential but lack 
neuronal morphology, as has been observed in the human neuroblastoma SH-SY5Y cell line. While it has 
been demonstrated that SH-SY5Y cells can be differentiated to yield a homogenous population of neuron­
like cells that can be used for investigation of CNS-relevant diseases, it remains that the tumor-origins of 
the cell line may result in genomic abnormalities that result in alternative functional responses to stimuli 
that must be considered when interpreting results obtained from these systems. Further, the use of primary 
mammalian neurons is limited by restrictions in propagation- once terminally differentiated into mature 
neuronal cultures, these cells can no longer be propagated. In vivo investigations of HAND are limited to 
animal models, frequently in transgenic rodent models whose non-human origins make it difficult to 
translate these results to true human pathogenesis.
Human embryonic stem cell (hESc) and human inducible pluripotent stem cell (hiPSC) 
technologies have emerged as promising approaches for the investigation of neurodegenerative disease in 
primary neurons of human origin. The application of varying differentiation protocols allows researchers 
to differentiate and expand hESc and hiPSCs into large quantities of functional neurons of specific 
subtypes pertinent to the pathologies under study. Numerous groups have reported success in establishing 
stem cell models for the investigation of human neurodegenerative disorders, including Alzheimer's, 
Parkinson's, and Huntington's diseases as well as for the study of human neurotropic viruses, including 
Herpes Simplex and Varicella Zoster (Tousley and Kegel-Gleason, 2016; Xiao et al., 2016; Yang et al., 
2016; Pourchet et al., 2017). Moreover, these model systems also carry potentially crucial epigenetic 
information, which is thought to play a vital role in disease pathologies. However, most methods for 
differentiating these cells are time-consuming with low conversion efficiency and lack reproducibility 
between different pluripotent cell lines used for the initial conversion of these cells into induced neurons 
(iN) (Hu et al., 2010).
Here, we describe a method for the direct induction of the H1- hESc line into functional iN cells 
by forced expression of a single transcription factor. A similar method has been previously demonstrated 
to convert both hEScs and hiPSCs into functional neurons with near 100% efficiency and purity. 
Neuronal induction of stem cells under this method rapidly and reproducibly generates functional iN cells 
in less than two weeks and provides a primary human neuronal model for the investigation of human 




1. H1-hESc have been derived from the inner cell mass of blastocytes and have been approved 
for use in federally funded research. These cells can be subjected to long term storage and amplified 
without affecting cell viability
2. These cells will grow very rapidly with a doubling time of ~12 hours. In contrast to most cell 
type culturing methods, H1-hESc cells will grow in small clumps forming islands in culture. These 
cells must be grown in colonies to maintain growth and pluripotency
3. Cells must be plated onto Matrigel-coated dishes; media components and substrates are critical 
to the induction of iN from these cells. See the Table 1 for a list of reagents.
4.3.2. Matrigel Coating of 6-well plates and 12mm glass coverslips
1. Maintain Matrigel frozen as a 10x stock at -20°C; thaw on ice and keep cold until ready for use
2. Dilute Matrigel stock into DMEM/F12 at 1x concentration to desired volume. Add 1mL 1x 
Matrigel per well for 6-well plate, or 80uL per glass coverslip. Incubate for 1 hour at 37°C
3. Remove media and plate cells directly into wells or onto coverslips without washing
4.3.3. Plating H1-hESc maintenance cultures
1. Gently thaw one vial (0.5mL) hESc only until frozen media is in solution
2. Add 2mL of hESc growth medium (See Table 2) and gently mix
3. Spin cells for 3 minutes at 200xgmax and aspirate supernatant
4. Resuspend the cell pellet in hESc plating medium (see Table 2) (volume = 2mL/well plated)
5. Plate 2mL of the cell suspension per well
6. After 24 hours, hESc grow into small, clumped islands with cells exhibiting protrusions at the 
edges of islands
7. Transfer cultures to hESc growth medium with a complete media exchange. Clumps of cells 
will grow into islands with smooth edges/no or few protrusions
8. Allow cells to grow to ~80% confluence before re-plating
4.3.4. Passage of H1-hESc maintenance cultures
1. Wash cells twice with cold dissociation medium (see Table 2) using 1mL/well
2. Incubate cultures with 1mL dissociation medium at 37°C for 3-4 minutes. Islands will round up 
and visibly shrink in size
3. Remove dissociation medium and gently add growth medium (1mL/well)
4. Carefully aspirate medium and replace with 1mL growth medium/well
5. Dislodge cells by washing with a 1000 μL pipette. Do not triturate cells
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6. Spin cells for 3 minutes at 200xgmax and aspirate supernatant. Resuspend cell pellet in hESc 
plating medium for a total volume = (# wells X 6) X 2mL
7. Plate 2mL of cell suspension per well. After 24 hours, transfer cultures to hESc growth 
medium with complete medium exchange and note passage number
4.3.5. Freezing H1-hESc maintenance cultures
1. Follow steps 1-6 described in “Passage of H1-hESc maintenance cultures”
2. Resuspend cell pellet in BAMBANKER (see Table 1) using 1mL/well.
3. Aliquot 500uL cell suspension into cryotubes
4. Place at -80°C overnight before transferring to liquid nitrogen for long term storage
4.3.6. Preparing H1-hESc cultures for differentiation
1. Follow steps 1-3 described in “Plating H1-hESc maintenance cultures”
2. Resuspend cell pellet in 4mL hESc plating medium
3. Plate 2mL of cell suspension per well (in a 6-well plate). After 24 hours, cells will grow in 
small, clumpy islands with protrusions at edges of islands
4. Transfer cultures in complete media exchange to hESc growth medium
5. Re-plate hESc cultures when reaching 80% confluence at a ratio of 1:3 (1 well → 3 wells of 6- 
well plate) in plating medium
6. After 24 hours, transfer hESc cultures to growth medium in a complete medium exchange. 
Grow cultures to ~80% confluence
7. Dislodge hESc and triturate harshly into single cell suspension. Re-plate hESc 1:1 with plating 
medium into a Matrigel coated 6-well plate
8. After 24 hours, perform a complete medium exchange to growth medium and let cultures grow 
until confluent (Day -2)
4.3.7. Lentiviral transformation of hESc
1. Prepare lentiviral particle in growth medium at desired viral dilution
2. Add lentiviral particle solution to cultures with a complete medium exchange (Day -1)
3. After 24 hours, perform a complete medium exchange to N3 medium (See Table 2) containing 
doxycycline (Day 0). At this time, it is also possible to maintain cells in mTeSR complete with 
doxycycline (See Table 2).
4. After 24 hours, transfer cultures to N3 medium containing doxycycline and puromycin (See 
Table 2) by complete medium exchange. (Day +1).
5. Perform a complete medium exchange daily using N3 medium containing doxycycline and 
82
puromycin (Day +2 through +5). Cells display vigorous process formation together with 
considerable cell death of non-infected cells driven by puromycin selection.
6. At Days +5 to +7, prepare induced neuron (iN) cells for re-plating
4.3.8. Long-term maintenance of iN cultures
1. Aspirate medium and wash cultures with PBS/1mM EDTA twice
2. Incubate with Accutase (See Table 1) for 3-5 minutes at 37°C, 1mL/well
3. Gently dislodge iN cells from wells and transfer to 15mL conical tube. Add 1mL N3 medium 
for each well of iN cells
4. Spin cells for 3 minutes at 200xgmax and remove supernatant
5. Resuspend iN cells in N3 medium containing 5% FBS and 1x doxycycline (See Table 1) as 
follows:
- Combine cells collected from one 6-well plate with 1.5mL of N3 medium containing serum and 
doxycycline.
- Add 1mL mouse P3 glia (for a total volume of 2.5mL)
6. Plate iN/glia cell suspension- 100□L per glass coverslip. Allow cells to adhere for 1-2 hours
7. Supplement each well with 500 □L N3 medium with serum/doxycycline
8. After 24 hours, perform complete medium exchange using N3 medium with 2.5% heat 
inactivated FBS and 1x doxycycline
9. Perform a half medium exchange every 3 days. After day 3 to 4, include FdUr or AraC in the 
medium to inhibit proliferation of non-neuronal (non-infected) cells
10. At Day 7 after re-plating, perform half-medium exchange with Neurobasal media, omitting 
doxycycline, for a gradual transition to serum free conditions
4.4. Representative results
Many existing protocols for the differentiation of hESc into human iN are lengthy, cumbersome 
procedures that make large-scale studies difficult and have been complicated by relatively low yields and 
low efficiency. The protocol described above allows for the direct conversion of hEScs into functional 
human induced neurons in less than 2 weeks. Upon initial plating in media containing ROCK inhibitor Y- 
27632 (Table 2), hES cells appear as clumpy islands with multiple spiky protrusions along the perimeter 
(Figure 2 A, B). ROCK inhibition Rho kinase has been demonstrated to support maintenance of stem cell 
phenotype prior to differentiation and improve the survival of hESc monolayers at the initiation of 
differentiation protocols (Vernardis et al., 2017). Transferring hESc cultures to growth medium (Day -2) 
removes ROCK inhibition and cell edges begin smoothing as cells adhere to Matrigel coating and 
continue to proliferate (Figure 2 C, D). When cultures have reached ~80% confluence, cells are infected 
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with lentiviral particles expressing the neuronal transcription factor neurogenin-2/puromycin resistance 
gene fusion protein, EGFP, and rtTA (reverse tetracycline-controlled transactivator) at the desired 
multiplicity of infection (MOI) (Day -1). 24 hours post-infection, cultures are exposed to doxycycline, a 
tetracycvline derivative capable of activating transcription at the TetO promoter (Day 0) (Figure 3). 
Cultures are maintained in the presence of doxycycline for the remainder of the induction protocol. On 
Day +1, cultures are exposed to both doxycycline and puromycin. The NgN2/puromycin resistance gene 
fusion protein ensures only successfully transduced cells expressing the NgN2 transcription factor will 
survive puromycin selection, allowing for the generation of a pure population of induced neurons. 
Following activation of doxycycline-induced gene expression at Day 0, transduced cells display rapid 
morphological changes and display a characteristically neuronal phenotype within 2-4 days of 
transcriptional activation. By Day +5 and +6, cells exhibit round cell bodies and continually extending 
neurite-like processes characteristic of human neurons (Figure 4). At this point, iN cells can be used for 
early down-stream applications, or more typically— are re-plated onto a feeder layer of mouse glia cells, 
to support healthy long-term cultures of hiN. Glia proliferation is controlled during long-term culture with 
the inclusion of 5-fluoro,2'-deoxyuridine (FdUr) or cytosine β-d-arabinofUranoside (AraC), potent 
inhibitors of mitotic cell division. It has been previously demonstrated that while iN induced via the 
forced expression of NgN2 begin exhibiting typical excitatory signals after 28 days in culture, neurons 
exhibit changes in protein expression as maturation continues. Therefore, continued culture to Day +40 
through +60 is recommended to generate mature neurons for experimentation. Indeed, a recently 
conducted proof-of-principal experiment failed to trigger the formation of actin-cofilin rods in induced 
neurons when stimulated shortly after re-plating with known rod inducers (data not shown). As rods have 
been identified in hippocampal and cortical neurites of post-mortem brains of Alzheimer's patients, this is 
hypothesized to be a consequence of an ‘immature' neuron that may not yet be expressing all 
components for signaling rather than an inability of human neurons to form rods (Minamide et al., 2000). 
To re-assess rod formation in induced neurons, cultures are currently undergoing long-term maintenance 
for experimentation after 40+ days of maturation in culture.
4.5. Discussion
Though neuronal cell lines and animal models have been widely used for the in vitro 
investigation of neurodegenerative disease, any results obtained from these models requires consideration 
of the differences between neuronal cell lines and primary neurons and that using neurons from non­
human origins may affect experimental outcomes and limit the applicability of results, particularly for a 
human host-specific virus such as HIV. Numerous studies have identified differences between neuronal 
cell lines— even cell lines differentiated into more neuron-like cells— and primary neurons, including 
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changes in receptor expression and function, as well as differential responses following exposure of 
neurotoxins (LePage et al., 2005; Edwards et al., 2007; Shipley et al., 2017). Stem cells have emerged as 
promising tool in the field of neurodegenerative research, allowing researchers to model brain disease 
directly in human neurons in instances where the availability of brain tissue is restricted. Here, we have 
demonstrated the rapid neural induction of hES cells with cultures exhibiting neuronal morphology by 6­
days post induction. This direct induction of neuronal phenotype requires the forced expression of 
neuronal transcription factor Ngn2, introduced to hESc cultures through the use of lentiviral particles 
expressing NgN2, puromycin resistance, EGFP, and rtTA genes under the regulation of the Tet-On 
system for doxycycline induced gene expression (Zhang et al., 2013; Das et al., 2016) and yields neuronal 
cultures of near 100% purity. Importantly, this method of direct induction has been demonstrated to 
convert iPSC to iN with similar success (Chanda et al., 2014) and can potentially be used to generate 
primary neurons with regional CNS specificity by modifying transcriptional activators transduced.
The approach outlined here is directed toward the establishment of a relevant neuronal model of 
human origin for the investigation of HIV-neuron interaction with a particular aim of evaluating the role 
of HIV envelope glycoprotein gp120 in the induction of neuronal cofilin-actin rods in primary human 
neurons. Gp120 serves as a viral surface protein recognizing host CD4 and chemokine co-receptors CCR5 
and CXCR4 and is among the most potent HIV neurotoxins with a well-documented role in 
neurodegeneration mechanisms underlying HIV-associated neurocognitive disorders. We have previously 
described a pathway to the formation of rods activated by gp120 interaction with HIV co-receptors CCR5 
and CXCR4 in rodent hippocampal and cortical neurons. Generation of rod-like inclusions is a cellular 
response to oxidative stress resulting from the rapid dephosphorylation (activation) of cofilin and 
subsequent saturation of actin filaments, inducing bundling into rod-like structure and have been 
implicated in the synaptic dysfunction underlying other neurodegenerative diseases (Bamburg et al., 2010; 
Goyal et al., 2013). However, results obtained from animal models of neurodegeneration do not 
necessarily recapitulate human disease, and indeed, attempts at translating results from animal models to 
human systems often end in failure (Zeiss, 2017; Dawson et al., 2018; Ransohoff, 2018). A human 
primary neuronal model for the investigation of gp120-mediated neurotoxicity is the first step in 
overcoming current barriers to research by establishing a species-relevant model while avoiding the 
limitations associated with the use of immortalized cell lines. The method described here for the induction 
of human primary neurons has the potential to improve our current understanding of the molecular 
mechanisms of HAND and better characterize a novel molecular pathway leading to synaptic dysfunction 
previously undescribed for HIV.
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4.6. Figures and Tables
Figure 4.1. Timeline to induction of human induced neurons (hiN). The induction of human embryonic 
stem cells (hESc) to hiN cells occurs rapidly with iN cells visible in culture by Day +6. hESc cells are 
grown to confluence and infected with lentiviral particles expressing NgN2-EGFP, puramycin resistance, 
and rrTA/TetO for one day before switching to medium containing Tet activator doxycycline (Day 0). On 
Day 1, cells are transferred to medium containing both doxycyclin and puromycin to select for transduced 
cells. Cells are maintained in this medium with daily full media changes until Day 5+, at which point hiN 
can be prepared for re-plating.
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Figure 4.2. Stem cell morphology when initially plated in hESc plating medium containing the ROCK 
inhibitor Y-2763 (A, B) and in hESc growth medium without the inhibitor (C, D). After initial plating, 
cells form small clumps, growing into islands of increasing diameter as they adhere to Matrigel coating. 
In the presence of Y-2763, cells along the perimeter of the islands show multiple small protrusions 
resembling spikes (A, B). Figure 2B shows a 40X enlargement of protrusions. Removal of Y-2763 from 
growth medium leads to cells becoming more rounded with smooth edges maintained as the islands grow 
more confluent (C, D).
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Figure 4.3. Schematic of direct induction of hESc to hiN using lentiviral vectors. hESc cells were 
transduced with 3 viruses with one expression neuronal transcription factor fusion protein 
NgN2/puromycin resistance, another expressing EGFP, and the final expressing the reverse tetracycline- 
controlled transactivator (rrTA) (Day -1). One day after infection, cells are exposed to doxycycline to 
initiate expression of transduced genes via Tet-On driven transcriptional activation (Day 0). Beginning 
Day +1, cells are exposed to medium containing both doxycycline and puromycin to select against non­
transduced hESc. By Day +6, hiN show neuronal process outgrowth and are ready to be re-plated for 
downstream applications.
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Figure 4.4. Final steps in the direct induction of hESc to iN cells— morphology of transduced cells on 
Day +4, +5, and +6 (A-C) of the protocol. After induction, the cells rapidly differentiate to demonstrate 
morphology characteristic of a neuronal phenotype. Note that by Day +5 and +6, cells have already begun 
to exhibit neuronal process outgrowth (B, C).
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Table 4.1. Media components and vendor information.
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Component Vendor Catalog Number Storage
Matrigel™ Corning 356234 -20ºC
mTeSR Plus (400mL basal∕100mL supplement) Stemcell Technologies 5825 4ºC
DMEM∕F'12 Fisher 11320082 4ºC
Hyclone FBS heat-inactivated Fisher 3007003H1 -20ºC
Y-27632 (ROCK Inhibitor) Stemcell Technologies 72302 -20ºC
0.5 M EDTA Lonza AccuGene 51234 4ºC
Doxycycline (1000X) Sigma Aldirch D1822 -20ºC
Puromycin (1000X) Thermo Fisher A1113802 -20ºC
N2 Supplement (100X) RND Systems AR009 -20ºC
B27 Supplement (50X) Gibco 17504-044 -20ºC
Insulin Sigma Aldrich 13536 -20ºC
Arabinoside C Sigma Aldrich 1162002 -20ºC
5'-fluoro-deoxy-uridine Sigma Aldrich F8791 -20ºC
Bambanker Fisher NC9582225 2-10ºC
Accumax Innovative Cell Technologies Inc. AM-105 -4ºC
Table 4.2. Media recipes
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Component Instructions
Thaw mTeSR plus supplement overnight at 4°C. Combine with 400mL basal mTeSR Plus 
and store at 4ºC. Add Pen/Strep at 100 U/mL or 5mL∕500mL medium. Warm to 37ºC
hESc Growth Medium before use.
Dilute Y27632 (ROCK inhibitor) into hESc growth medium at 5μM immediately before
hESc Plating Medium plating. Do not store.
Dissociation Medium Dilute 0.5M EDTA in PBS to 1mM
N3 Medium for iN (50mL) 48mL DMEM∕F12
0.5mL N2 supplement (100X) 




—when called for— 50μL puromycin (1000X)
Neurobasal (50mL) 49mL Neurobasal
1mL N21max supplement (50X) 
0.125mL Pen/Strep (10,000 U/mL) 
0.125 mL Glutamax
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Chapter 5: General Conclusions
5.1. General Overview
Since its emergence in the early 1980s, the human immunodeficiency virus (HIV) and resulting 
acquired immunodeficiency syndrome (AIDS) have been responsible for 35 million deaths and more than 
70 million infections worldwide (UNAIDS, 2019). The implementation of combination antiretroviral 
therapy (cART) as the primary treatment regimen has shifted HIV/AIDS from an acute infection to a 
chronic disease with new challenges emerging in the form of associated comorbidities that can have 
profound impacts on quality of life. Included among these are the cognitive, motor, and behavioral 
abnormalities experienced by upwards of 50% of infected individuals, referred to as HIV-1-associated 
neurocognitive disorders (HAND)(Kaul et al., 2005; Saylor et al., 2016).
HAND develops over the course of infection in people living with HIV (PLWH) and is classified 
into three categories according to the degree of cognitive impairment— asymptomatic neurocognitive 
impairment (ANI), mild neurocognitive disorder (MNI), and the most severe, HIV-associated dementia 
(HAD). Prior to the introduction of antiretroviral therapy in the early 1990s, 20-30% of those infected 
with HIV developed HAD (Ciccarelli, 2020). Characterized by subcortical dementia with impairments in 
both cognitive and motor functions, brain atrophy, and neuronal loss, the incidence of HAD has seen a 
dramatic decline (~2% of the population of PLWH) over the last two decades (Saylor et al., 2016). While 
HAD has declined, the milder forms of HAND persist and are expected to increase in prevalence with the 
aging population of PLWH. Those affected by ANI and MNI often present with symptoms similar to 
cognitive impairments arising from other causes and include shortened attention span, mood disorders, 
confusion, and impairments in fine motor skills (Ciccarelli, 2020). These impairments, while mild in 
comparison to HIV dementia, continue to have profound impacts on the quality of life for those affected. 
Not surprisingly, neuropathology underlying these milder forms of HAND differs from HAD, and 
strikingly, post-mortem examinations no longer observe the encephalitis and widespread neuronal loss 
previously reported for HAD (Gelman, 2015; Saylor et al., 2016). Rather, HAND in the post-cART era is 
likely to be the result of functional alterations in neurons arising from dysregulation of neuronal 
homeostasis and impaired neuronal plasticity characterized by synaptodendritic damage (Smith et al., 
2018).
HIV invades the central nervous system (CNS) within weeks of initial viral exposure and remains a 
site of persistent infection regardless of adherence to antiretroviral regiment (Eden et al., 2007; Sturdevant 
et al., 2015). HIV infection of the CNS is associated with activation of microglia and astrocytes, as well 
as the induction of inflammatory and neurotoxic insults, which are suspected to stimulate a progressive 
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synaptic degeneration manifested in cognitive decline. Despite the increasing prevalence of HAND, the 
underlying molecular and cellular mechanisms are poorly understood and are thought to consist of a 
combination of direct viral infection of cells of the CNS and indirect mechanisms involving inflammatory 
cytokines, metabolites, and neurotoxic effects of viral proteins, including the envelope glycoprotein 
gp120. The neurotoxicity of gp120 has been widely reported, with a demonstrated role in inducing 
neuronal apoptosis, dysregulation of neuronal receptors, and notably— synaptic and dendritic damage 
(Lipton et al., 1991; Kaul et al., 2001; Chen et al., 2002; Iskander et al., 2004; Melli et al., 2006).
Intriguingly, HAND and Alzheimer's disease share many common neurotoxic pathways and 
individuals with HAND show increased synthesis of amyloid-β (Aβ) as well as increased phosphorylation 
of Tau (Canet et al., 2018). Both Aβ and Tau are neurotoxic proteins implicated in the progression of 
Alzheimer's disease with a role in mediating synaptic dysfunction. Notably, we have previously identified 
a neurotoxic signaling pathway stimulated by Aβ oligomers and proinflammatory cytokines that 
contributes to the synaptic dysfunction observed in Alzheimer's disease. This pathway requires the 
expression of cellular prion protein (PrPc) and the activity of NADPH oxidase-2 (NOX2) embedded in 
coalesced lipid raft microdomains. Subsequent ROS generation is causative to the formation and 
accumulation of rod-like cofilin-actin inclusions (rods) in neuronal processes, which contribute to 
synaptic dysfunction via sequestration of cofilin and actin from dendritic spines, as well as disruption of 
vesicular transport resulting from occlusion of neurites containing rods (3, 4). Lipid rafts, transient 
cholesterol and sphingolipid enriched microdomains in the plasma membrane, serve as coalescing 
signaling platforms promoting clustering of receptors and components of receptor-activated signaling 
cascades, thereby initiating cellular signaling (5). Protein association with lipid rafts as a mechanism for 
regulating signaling has been observed for a number of neurodegenerative diseases, including the 
pathway to rod formation described for Alzheimer's disease (6). Notably, HIV not only infects host cells 
via binding of gp120 to the CD4 receptor and CCR5/CXCR4 co-receptors localized in host-cell lipid raft 
domains but gp120 exposure of neurons similarly induces enhanced lipid raft coalescence and activation 
of NADPH-oxidase mediated generation of ROS.
Given the numerous similarities between HAND and Alzheimer's disease, we hypothesized that 
gp120 interaction with lipid-raft localized co-receptors CCR5 and CXCR4 would similarly induce the 
formation of actin-cofilin rods through the same pathway as Ab. To test this hypothesis, we generated 3 
questions (aims) we wished to address:
1) What are the consequences of distinct gp120 co-receptor tropism on the generation of rod-like cofilin­
actin inclusions in primary rodent neurons?
2) Does gp120 induces ROS and cofilin-actin rods in SH-SY5Y human neuroblastoma cells?
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3) Can mature human neurons derived from human embryonic stem cells serve as a more relevant model 
for the investigation of gp120 induced actin-cofilin rods?
Chapters 2, 3, and 4 of this dissertation address these aims, and the results from each chapter are 
briefly discussed below:
5.2. Chapter 2: Direct Interaction of HIV gp120 with Neuronal CXCR4 and CCR5 Receptors Induces 
Cofilin-Actin Rod Pathology via a Cellular Prion Protein- and NOX- Dependent Mechanism
The experiments in Chapter 2 explored the ability of gp120 to induce the formation of cofilin­
actin rods via a PrPC / NOX2 dependent pathway, and further characterized the induction of rods in the 
context of gp120 tropism. Our results reveal for the first time gp120-mediated induction of cofilin-actin 
rods as a novel mechanism underlying synaptic dysfunction in HAND. Exposing E16 mouse hippocampal 
neurons to all strains of gp120 tested (dual-, R5-, and X4-tropic) led to a significant increase in number of 
rods present in neurites. We also provide evidence that gp120-mediated rod induction is dependent on the 
activation and subsequent generation of superoxide by NOX2, as well as the expression of PrPC in lipid 
rafts. Though we demonstrate the involvement of both CCR5 and CXCR4 co-receptors in the activation 
of this pathway, our results suggest that there are receptor-specific differences in the neuronal response to 
gp120 induced signaling. Both R5- and X4- tropic strains of gp120 induced a significant rod response; 
however, the inhibition of CXCR4 mediated signaling alone rescued neurons from rod induction. In R5- 
tropic strains, inhibiting the CCR5 receptor resulted in a nominal decrease in the number of rods detected, 
suggesting that blocking gp120/CCR5 signaling achieves only a partial block of rod induction. Recent 
experiments have shown Ab-mediated rod induction is inhibited by maraviroc, the CCR5 receptor 
antagonist (data not shown). Importantly, the concentration of inhibitor used by investigators in this study 
was 100X the concentration we used to inhibit gp120 interaction with the receptor. Our partial block may 
be due to insufficient inhibitor concentration and warrants further study. These results identify a 
previously undescribed pathway to synaptic dysfunction mediated by gp120 highlighting new targets for 
therapeutic intervention.
5.3. Chapter 3: Lipid Raft Coalescence Links Gp120 Induced Oxidative Stress to Neurodegeneration
Having demonstrated the gp120-mediated induction of rods in E16 murine mouse hippocampal 
neurons, we next sought to observe the same pathology in neurons of human origin. We first exposed SH- 
SY5Y human neuroblastoma cells to gp120 and quantified the response by the increase in lipid raft size 
and stability (coalescence). We next quantified ROS production and confirmed NOX2 activity by 
measuring the response of neurons to gp120 exposure over time and quantifying the amount of NOX2 
cytosolic subunit p67PHOX associated with the plasma membrane. We found SH-SY5Y responded to 
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gp120 exposure with a dose-dependent increase in lipid raft coalescence and a corresponding activation of 
NOX2. This activation of NOX2 induces a rapid rise in ROS, with superoxide levels elevated over control 
up to 2.5 hours post-exposure. Given the similar response to gp120 between the neurons of rodent and 
human origin, we then used differentiated SH-SY5Y cells to evaluate rod induction by gp120 in a human 
model. We were unable to detect any rod formation, as discussed in Chapter 3. However, it is possible 
that the reportedly low levels of endogenous PrPC expressed by these cells is a contributing factor, as the 
expression of PrPC is required for the induction of rod formation. These results suggest that SH-SY5Y 
cells respond to gp120 in a manner similar to what is seen for the mouse neuronal respond to gp120. If the 
absence of detectable rods in SH-SY5Y is truly due to low or absent expression of PrPC, transfection or 
other genetic manipulation to force the expression of the protein may be a means of generating a 
functional human neuronal model for investigation rod pathology in HAND and other neurodegenerative 
disease.
5.4. Chapter 4: Establishing a Protocol for the Direct Induction of Human Embryonic Stem-Cell Derived 
Glutamatergic Neurons: A Model for Investigation of Hand
While SH-SY5Y cells provide an attractive alternative to murine cells for the investigation of the rod 
induction pathway, it remains that the immortal-cell line background can call into question the relevancy 
of results. Advances in stem cell technology have offered a potential solution to the problems associated 
with the use of non-human models and cell lines to investigate human disease. Many protocols for stem 
cell differentiation are time-consuming, complicated and affected by low yield and lack of reproducibility. 
In this chapter, we describe a method for the direct induction of human embryonic stem cells to human 
neurons. Using this method, the forced expression of transcription factor neurogenin-2 under control of 
TetOn inducible expression plasmid system generated human glutamatergic neurons with near 100% 
conversion in less than 2 weeks. These human neurons provide a new tool for investigating HAND in a 
primary human neuronal model.
5.5. Concluding Remarks
The results presented here highlight a novel pathway to synaptic dysfunction mediated by HIV 
glycoprotein gp120 directly interacting with co-receptors CCR5 and CXCR4 on the neuronal membrane 
of murine neurons. We further demonstrate that gp120 is capable of initiating lipid-raft coalescence and 
generation of superoxide by NOX2- critical steps in the pathway to rod induction observed for not only 
gp120 mediated rod formation in rodent neurons, but also rod induction by Alzheimer's associated Aβ 
peptide oligomers, in the human neuroblastoma SH-SY5Y cell line . Though most current in vitro models 
for investigating rod formation rely on the use of murine primary neurons, it remains that rodents are not 
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humans, and accordingly, to be relevant to human disease rod induction must be recapitulated in human 
neurons. While it is known that human neurons are capable of producing pathologic rods, as evidenced by 
post-mortem examinations of Alzheimer's brains where the presence of rods were detected only in 
diseased brains, to our knowledge rod induction has not been demonstrated in an in vitro human model 
(Minamide et al., 2000). Because SH-SY5Y cell scan be differentiated to a more neuronal phenotype 
exhibiting long, neuritic processes, we sought to confirm gp120 is capable of inducing rods in a human 
model. While we were unable to detect rod induction in the experiments described here, it is still possible 
that this cell line could be developed as a neuronal model for rod investigation in an easily accessible cell 
line. In addition to the development of an SH-SY5Y model for rod investigation, we also sought to 
establish a primary human neuronal model through the differentiation of human embryonic stem cells. 
The use of stem cells has emerged as a powerful tool in the field of neurodegeneration, allowing 
researchers to not only model brain disease directly in human neurons in instances where the availability 
of brain tissue is restricted. We demonstrate the successful generation of human glutamatergic neurons 
employing a method of direct induction yielding neuronal cells within 2 weeks. We are currently awaiting 
maturation of these neurons before evaluating for the expression of gp120 co-receptors and the ability to 
induce rods in response to known rod inducing stimuli. The PrPC/NOX2 dependent pathway to rod 
induction described here highlights several potential new targets for therapeutic approaches to the 
management of not only HIV associated neurocognitive disorders, but other neurodegenerative diseases 
in which rod induction may underly synaptic dysfunctions.
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